<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37458987</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.</ArticleTitle><Pagination><StartPage>6476</StartPage><EndPage>6529</EndPage><MedlinePgn>6476-6529</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-023-03502-9</ELocationID><Abstract><AbstractText>Neurodegenerative diseases (NDDs) and neuropsychiatric disorders (NPDs) are two common causes of death in elderly people, which includes progressive neuronal cell death and behavioral changes. NDDs include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, and motor neuron disease, characterized by cognitive defects and memory impairment, whereas NPDs include depression, seizures, migraine headaches, eating disorders, addictions, palsies, major depressive disorders, anxiety, and schizophrenia, characterized by behavioral changes. Mounting evidence demonstrated that NDDs and NPDs share an overlapping mechanism, which includes post-translational modifications, the microbiota-gut-brain axis, and signaling events. Mounting evidence demonstrated that various drug molecules, namely, natural compounds, repurposed drugs, multitarget directed ligands, and RNAs, have been potentially implemented as therapeutic agents against NDDs and NPDs. Herein, we highlighted the overlapping mechanism, the role of anxiety/stress-releasing factors, cytosol-to-nucleus signaling, and the microbiota-gut-brain axis in the pathophysiology of NDDs and NPDs. We summarize the therapeutic application of natural compounds, repurposed drugs, and multitarget-directed ligands as therapeutic agents. Lastly, we briefly described the application of RNA interferences as therapeutic agents in the pathogenesis of NDDs and NPDs. Neurodegenerative diseases and neuropsychiatric diseases both share a common signaling molecule and molecular phenomenon, namely, pro-inflammatory cytokines, &#x3b3;CaMKII and MAPK/ERK, chemokine receptors, BBB permeability, and the gut-microbiota-brain axis. Studies have demonstrated that any alterations in the signaling mentioned above molecules and molecular phenomena lead to the pathophysiology of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, and neuropsychiatric disorders, such as bipolar disorder, schizophrenia, depression, anxiety, autism spectrum disorder, and post-traumatic stress disorder.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, New Delhi, Delhi, 110042, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Advani</LastName><ForeName>Dia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, New Delhi, Delhi, 110042, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, New Delhi, Delhi, 110042, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambasta</LastName><ForeName>Rashmi K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, New Delhi, Delhi, 110042, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Pravir</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7444-2344</Identifier><AffiliationInfo><Affiliation>Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, New Delhi, Delhi, 110042, India. pravirkumar@dtu.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="Y">Huntington Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067877" MajorTopicYN="Y">Autism Spectrum Disorder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drug repurposing</Keyword><Keyword MajorTopicYN="N">Micro RNAs</Keyword><Keyword MajorTopicYN="N">Microbiota-gut-brain axis</Keyword><Keyword MajorTopicYN="N">Natural compounds</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric disorders</Keyword><Keyword MajorTopicYN="N">Post-translational modifications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>15</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37458987</ArticleId><ArticleId IdType="doi">10.1007/s12035-023-03502-9</ArticleId><ArticleId IdType="pii">10.1007/s12035-023-03502-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol 9:a028035. https://doi.org/10.1101/CSHPERSPECT.A028035</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/CSHPERSPECT.A028035</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId><ArticleId IdType="pmc">5495060</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer&#x2019;s disease. Lancet 397:1577&#x2013;1590. https://doi.org/10.1016/S0140-6736(20)32205-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType="pubmed">33667416</ArticleId><ArticleId IdType="pmc">8354300</ArticleId></ArticleIdList></Reference><Reference><Citation>Matej R, Tesar A, Rusina R (2019) Alzheimer&#x2019;s disease and other neurodegenerative dementias in comorbidity: a clinical and neuropathological overview. Clin Biochem 73:26&#x2013;31. https://doi.org/10.1016/J.CLINBIOCHEM.2019.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CLINBIOCHEM.2019.08.005</ArticleId><ArticleId IdType="pubmed">31400306</ArticleId></ArticleIdList></Reference><Reference><Citation>Uwishema O, Onyeaka H, Badri R et al (2022) The understanding of Parkinson&#x2019;s disease through genetics and new therapies. Brain Behav 12:e2577. https://doi.org/10.1002/BRB3.2577</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BRB3.2577</ArticleId><ArticleId IdType="pubmed">35451243</ArticleId><ArticleId IdType="pmc">9120874</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC et al (2022) Potential disease-modifying therapies for Huntington&#x2019;s disease: lessons learned and future opportunities. Lancet Neurol 21:645&#x2013;658. https://doi.org/10.1016/S1474-4422(22)00121-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00121-1</ArticleId><ArticleId IdType="pubmed">35716694</ArticleId><ArticleId IdType="pmc">7613206</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister B, Gusella JF, Landwehrmeyer GB et al (2021) Timing and impact of psychiatric, cognitive, and motor abnormalities in Huntington disease. Neurology 96:e2395&#x2013;e2406. https://doi.org/10.1212/WNL.0000000000011893</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011893</ArticleId><ArticleId IdType="pubmed">33766994</ArticleId><ArticleId IdType="pmc">8166441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead RJ, Shan N, Reiser HJ et al (2022) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 223(22):185&#x2013;212. https://doi.org/10.1038/s41573-022-00612-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-022-00612-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray NJ, O&#x2019;Donovan MC (2018) The genetics of neuropsychiatric disorders. Brain Neurosci Adv 2:239821281879927. https://doi.org/10.1177/2398212818799271</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2398212818799271</ArticleId></ArticleIdList></Reference><Reference><Citation>Stilo SA, Murray RM (2019) Non-genetic factors in schizophrenia. Curr Psychiatry Rep 21:1&#x2013;10. https://doi.org/10.1007/S11920-019-1091-3/FIGURES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11920-019-1091-3/FIGURES/1</ArticleId></ArticleIdList></Reference><Reference><Citation>Spark DL, Fornito A, Langmead CJ, Stewart GD (2022) Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics. Transl Psychiatry 121(12):1&#x2013;11. https://doi.org/10.1038/s41398-022-01904-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01904-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Otte C, Gold SM, Penninx BW et al (2016) Major depressive disorder. Nat Rev Dis Prim 21(2):1&#x2013;20. https://doi.org/10.1038/nrdp.2016.65</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.65</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Berk M, Brietzke E et al (2020) Bipolar disorders. Lancet 396:1841&#x2013;1856. https://doi.org/10.1016/S0140-6736(20)31544-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31544-0</ArticleId><ArticleId IdType="pubmed">33278937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirvani Farsani Z, Zahirodin A, Ghaderian SMH et al (2020) The role of long non-coding RNA MALAT1 in patients with bipolar disorder. Metab Brain Dis 35:1077&#x2013;1083. https://doi.org/10.1007/s11011-020-00580-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-020-00580-9</ArticleId><ArticleId IdType="pubmed">32458337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokoloff P, Diaz J, Foll BL et al (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord-Drug Targets Formerly Current Drug Targets-CNS Neurol Disord 5(1):25&#x2013;43. https://doi.org/10.2174/187152706775535687</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152706775535687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 86(8):413&#x2013;426. https://doi.org/10.1038/nrn2153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquini S, Contri C, Merighi S et al (2022) Adenosine receptors in neuropsychiatric disorders: fine regulators of neurotransmission and potential therapeutic targets. Int J Mol Sci 1219(23):1219. https://doi.org/10.3390/IJMS23031219</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS23031219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhamzeh M, Moravej FG, Arabi M et al (2021) The roles of serotonin in neuropsychiatric disorders. Cell Mol Neurobiol 426(42):1671&#x2013;1692. https://doi.org/10.1007/S10571-021-01064-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10571-021-01064-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Athar T, Al Balushi K, Khan SA (2021) Recent advances on drug development and emerging therapeutic agents for Alzheimer&#x2019;s disease. Mol Biol Rep 48:5629&#x2013;5645. https://doi.org/10.1007/S11033-021-06512-9/FIGURES/8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11033-021-06512-9/FIGURES/8</ArticleId><ArticleId IdType="pubmed">34181171</ArticleId><ArticleId IdType="pmc">8236749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouda NA, Elkamhawy A, Cho J (2022) Emerging therapeutic strategies for Parkinson&#x2019;s disease and future prospects: a 2021 update. Biomed 371(10):371. https://doi.org/10.3390/BIOMEDICINES10020371</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES10020371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovedhi Aggarwal MFACM (2011) Therapeutic management of late-stage Parkinson&#x2019;s disease: review of the Movement Disorder Society&#x2019;s guidelines. Ann Long-Term Care 19</Citation></Reference><Reference><Citation>Kim A, Lalonde K, Truesdell A et al (2021) New avenues for the treatment of Huntington&#x2019;s disease. Int J Mol Sci 8363(22):8363. https://doi.org/10.3390/IJMS22168363</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS22168363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J (2019) Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int J Mol Sci 2616(20):2616. https://doi.org/10.3390/IJMS20112616</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS20112616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JH, Rempe T, Whitmire N et al (2022) Therapeutic advances in multiple sclerosis. Front Neurol 13:824926. https://doi.org/10.3389/FNEUR.2022.824926/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2022.824926/BIBTEX</ArticleId><ArticleId IdType="pubmed">35720070</ArticleId><ArticleId IdType="pmc">9205455</ArticleId></ArticleIdList></Reference><Reference><Citation>De Angelis F, John NA, Brownlee WJ (2018) Disease-modifying therapies for multiple sclerosis. BMJ 363. https://doi.org/10.1136/BMJ.K4674</Citation></Reference><Reference><Citation>Shim KH, Sharma N, An SSA (2022) Prion therapeutics: lessons from the past. Prion 16:265. https://doi.org/10.1080/19336896.2022.2153551</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2022.2153551</ArticleId><ArticleId IdType="pubmed">36515657</ArticleId><ArticleId IdType="pmc">9754114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew SJ, Price RB, Charney DS (2008) Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet Part C Semin Med Genet 148C:89&#x2013;98. https://doi.org/10.1002/AJMG.C.30172</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/AJMG.C.30172</ArticleId><ArticleId IdType="pubmed">18412102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandelow B, Michaelis S, Wedekind D (2022) Treatment of anxiety disorders. Dialogues Clin Neurosci 19:93&#x2013;107. 10.31887/DCNS.2017.19.2/BBANDELOW</Citation></Reference><Reference><Citation>Voineskos D, Daskalakis ZJ, Blumberger DM (2020) Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat 16:221&#x2013;234. https://doi.org/10.2147/NDT.S198774</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S198774</ArticleId><ArticleId IdType="pubmed">32021216</ArticleId><ArticleId IdType="pmc">6982454</ArticleId></ArticleIdList></Reference><Reference><Citation>Guery D, Rheims S (2021) Clinical management of drug resistant epilepsy: a review on current strategies. Neuropsychiatr Dis Treat 17:2229&#x2013;2242. https://doi.org/10.2147/NDT.S256699</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S256699</ArticleId><ArticleId IdType="pubmed">34285484</ArticleId><ArticleId IdType="pmc">8286073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira AC, Oliveira J, Silva S et al (2021) Inflammation in bipolar disorder (BD): identification of new therapeutic targets. Pharmacol Res 163:105325. https://doi.org/10.1016/J.PHRS.2020.105325</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHRS.2020.105325</ArticleId><ArticleId IdType="pubmed">33278569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg SD, Elarova I, Ruben M et al (2004) Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 296(29):1053&#x2013;1064. https://doi.org/10.1023/B:NERE.0000023593.77052.F7</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:NERE.0000023593.77052.F7</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuttler K, Hassan M, Carr J et al (2021) Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders. Open Biol 11. https://doi.org/10.1098/RSOB.210091</Citation></Reference><Reference><Citation>Rudrapal M, Khairnar SJ, Jadhav AG (2020) Drug repurposing (DR): an emerging approach in drug discovery. Drug Repurposing - Hypothesis, Mol Asp Ther Appl. https://doi.org/10.5772/INTECHOPEN.93193</Citation></Reference><Reference><Citation>Wen H, Jung H, Li X (2015) Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J 17:1327. https://doi.org/10.1208/S12248-015-9814-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/S12248-015-9814-9</ArticleId><ArticleId IdType="pubmed">26276218</ArticleId><ArticleId IdType="pmc">4627459</ArticleId></ArticleIdList></Reference><Reference><Citation>Vafadari B (2021) Stress and the role of the gut&#x2013;brain axis in the pathogenesis of schizophrenia: a literature review. Int J Mol Sci 22. https://doi.org/10.3390/IJMS22189747</Citation></Reference><Reference><Citation>Michalska P, Le&#xf3;n R (2020) When it comes to an end: oxidative stress crosstalk with protein aggregation and neuroinflammation induce neurodegeneration. Antioxidants 740(9):740. https://doi.org/10.3390/ANTIOX9080740</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ANTIOX9080740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimson A, Schlosser M, Huntley JD, Marchant NL (2018) Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review. BMJ Open 8:e019399. https://doi.org/10.1136/BMJOPEN-2017-019399</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJOPEN-2017-019399</ArticleId><ArticleId IdType="pubmed">29712690</ArticleId><ArticleId IdType="pmc">5969723</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobos SN, Bennett SA, Torrente MP (2019) The impact of histone post-translational modifications in neurodegenerative diseases. Biochim Biophys Acta - Mol Basis Dis 1865:1982&#x2013;1991. https://doi.org/10.1016/J.BBADIS.2018.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBADIS.2018.10.019</ArticleId><ArticleId IdType="pubmed">30352259</ArticleId></ArticleIdList></Reference><Reference><Citation>Polajnar M, &#x17d;erovnik E (2014) Impaired autophagy: a link between neurodegenerative and neuropsychiatric diseases. J Cell Mol Med 18:1705&#x2013;1711. https://doi.org/10.1111/jcmm.12349</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12349</ArticleId><ArticleId IdType="pubmed">25139375</ArticleId><ArticleId IdType="pmc">4196646</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryskalin L, Limanaqi F, Frati A et al (2018) mTOR-related brain dysfunctions in neuropsychiatric disorders. Int J Mol Sci 19</Citation></Reference><Reference><Citation>Young FB, Butland SL, Sanders SS et al (2012) Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases. Prog Neurobiol 97:220&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2011.11.002</ArticleId><ArticleId IdType="pubmed">22155432</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkhowa B, Mehan S, Sethi P, Prajapati A (2022) Activation of SIRT-1 signalling in the prevention of bipolar disorder and related neurocomplications: target activators and influences on neurological dysfunctions. Neurotox Res 40(2):670&#x2013;686</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-022-00480-z</ArticleId><ArticleId IdType="pubmed">35156173</ArticleId></ArticleIdList></Reference><Reference><Citation>Inestrosa NC, Montecinos-Oliva C, Fuenzalida M (2012) Wnt signaling: role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmacol 7:788&#x2013;807</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-012-9417-5</ArticleId><ArticleId IdType="pubmed">23160851</ArticleId></ArticleIdList></Reference><Reference><Citation>Siafarikas N, Aln&#xe6;s D, Monereo-Sanchez J et al (2021) Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer&#x2019;s disease with dementia. Int Psychogeriatrics 33:1217&#x2013;1228. https://doi.org/10.1017/S1041610221000934</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610221000934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenqi L, Duan J, Zhang W et al (2021) Relationship between neuropsychiatric symptoms and cognitive functions in patients with cognitive impairment. Psychogeriatrics 21:773&#x2013;782. https://doi.org/10.1111/psyg.12738</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/psyg.12738</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia AS, Cardoso A, Vale N (2021) Highlighting immune system and stress in major depressive disorder, Parkinson&#x2019;s, and Alzheimer&#x2019;s diseases, with a connection with serotonin. Int J Mol Sci 22</Citation></Reference><Reference><Citation>Ross JA, Gliebus G, Van Bockstaele EJ (2018) Stress induced neural reorganization: a conceptual framework linking depression and Alzheimer&#x2019;s disease. Prog Neuro-Psychopharmacology Biol Psychiatry 85:136&#x2013;151</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2017.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moret C, Briley M (2011) The importance of norepinephrine in depression. Neuropsychiatr Dis Treat 7:9. https://doi.org/10.2147/NDT.S19619</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S19619</ArticleId><ArticleId IdType="pubmed">21750623</ArticleId><ArticleId IdType="pmc">3131098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivolap YP (2021) Serotonin-norepinephrine reuptake inhibitors in psychiatry and neurology. Zhurnal Nevrol i Psikhiatrii Im SS Korsakova 121:141&#x2013;146. https://doi.org/10.17116/JNEVRO2021121081141</Citation><ArticleIdList><ArticleId IdType="doi">10.17116/JNEVRO2021121081141</ArticleId></ArticleIdList></Reference><Reference><Citation>Licinio J, Gold PW (1991) 4 Role of corticotrophin releasing hormone 41 in depressive illness. Baillieres Clin Endocrinol Metab 5:51&#x2013;58. https://doi.org/10.1016/S0950-351X(05)80096-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0950-351X(05)80096-5</ArticleId><ArticleId IdType="pubmed">2039428</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekhar A, Truitt W, Rainnie D, Sajdyk T (2009) Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8:209&#x2013;219. https://doi.org/10.1080/10253890500504557</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890500504557</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A et al (2022) Multiple aspects of inappropriate action of renin&#x2013;angiotensin, vasopressin, and oxytocin systems in neuropsychiatric and neurodegenerative diseases. J Clin Med 908(11):908. https://doi.org/10.3390/JCM11040908</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11040908</ArticleId></ArticleIdList></Reference><Reference><Citation>Vashadze SV (2015) Serotonin and depression. BMJ 350:19&#x2013;21. https://doi.org/10.1136/BMJ.H1771</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.H1771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J (2021) Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer&#x2019;s disease. Bioorg Med Chem Lett 49:128275. https://doi.org/10.1016/J.BMCL.2021.128275</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BMCL.2021.128275</ArticleId><ArticleId IdType="pubmed">34311086</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos R, Carrera I, Mart&#xed;nez O et al (2021) Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson&#x2019;s disease. Drug Dev Res 82:695&#x2013;706. https://doi.org/10.1002/DDR.21784</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/DDR.21784</ArticleId><ArticleId IdType="pubmed">33458869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen C, Mondoloni S, Le Borgne T et al (2021) Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety. Neuron 109:2604&#x2013;2615.e9. https://doi.org/10.1016/J.NEURON.2021.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2021.06.013</ArticleId><ArticleId IdType="pubmed">34242565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ressler KJ, Nemeroff CB (1999) Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 46:1219&#x2013;1233. https://doi.org/10.1016/S0006-3223(99)00127-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3223(99)00127-4</ArticleId><ArticleId IdType="pubmed">10560027</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakamata Y, Mizukami S, Izawa S et al (2022) Implicit and explicit emotional memory recall in anxiety and depression: role of basolateral amygdala and cortisol-norepinephrine interaction. Psychoneuroendocrinology 136:105598. https://doi.org/10.1016/J.PSYNEUEN.2021.105598</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSYNEUEN.2021.105598</ArticleId><ArticleId IdType="pubmed">34894424</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoshita T, Hirano T (2021) Norepinephrine facilitates induction of long-term depression through &#x3b2;-adrenergic receptor at parallel fiber-to-Purkinje cell synapses in the flocculus. Neuroscience 462:141&#x2013;150. https://doi.org/10.1016/J.NEUROSCIENCE.2020.05.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROSCIENCE.2020.05.037</ArticleId><ArticleId IdType="pubmed">32502572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T, Inoshita T (2021) Contribution of norepinephrine to cerebellar long-term depression and motor learning. Contemp Clin Neurosci 337&#x2013;348. https://doi.org/10.1007/978-3-030-75817-2_16</Citation></Reference><Reference><Citation>Goddard AW, Ball SG, Martinez J et al (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27:339&#x2013;350. https://doi.org/10.1002/DA.20642</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/DA.20642</ArticleId><ArticleId IdType="pubmed">19960531</ArticleId></ArticleIdList></Reference><Reference><Citation>Mausbach BT, Ancoli-Israel S, Von K&#xe4;nel R et al (2006) Sleep disturbance, norepinephrine, and D-dimer are all related in elderly care-givers of people with Alzheimer disease. Sleep 29:1347&#x2013;1352. https://doi.org/10.1093/SLEEP/29.10.1347</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/SLEEP/29.10.1347</ArticleId><ArticleId IdType="pubmed">17068989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmeister JD, Kelm-Nelson CA, Ciucci MR (2021) Quantification of brainstem norepinephrine relative to vocal impairment and anxiety in the Pink1-/- rat model of Parkinson disease. Behav Brain Res 414:113514. https://doi.org/10.1016/J.BBR.2021.113514</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2021.113514</ArticleId><ArticleId IdType="pubmed">34358571</ArticleId><ArticleId IdType="pmc">8393386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmeister JD, Kelm-Nelson CA, Ciucci MR (2022) Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease. Behav Brain Res 418:113642. https://doi.org/10.1016/J.BBR.2021.113642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2021.113642</ArticleId><ArticleId IdType="pubmed">34755639</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersielis K, Yasrebi A, Roepke T (2021) Intermittent fasting alters cognition, anxiety-like behavior, and hippocampal norepinephrine content in aged mice. FASEB J 35. https://doi.org/10.1096/FASEBJ.2021.35.S1.04428</Citation></Reference><Reference><Citation>Tach&#xe9; Y (2015) Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia. Neurogastroenterol Motil 27:1&#x2013;6. https://doi.org/10.1111/NMO.12495</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/NMO.12495</ArticleId><ArticleId IdType="pubmed">25557223</ArticleId><ArticleId IdType="pmc">4389773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, Jain R, Chawla N, Raghav R (2022) Serum corticotrophin releasing factor (CRF) and its correlation with stress and craving in detoxified opioid-dependent subjects. Asian J Psychiatr 68:102964. https://doi.org/10.1016/J.AJP.2021.102964</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AJP.2021.102964</ArticleId><ArticleId IdType="pubmed">34923378</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp DJ, Whitman BA, Wills TA et al (2011) Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav Immun 25:S146&#x2013;S154. https://doi.org/10.1016/J.BBI.2011.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBI.2011.02.018</ArticleId><ArticleId IdType="pubmed">21377524</ArticleId><ArticleId IdType="pmc">3138123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher L, Oquendo MA, Burke AK et al (2013) Combined dexamethasone suppression&#x2013;corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers. J Affect Disord 151:1108&#x2013;1112. https://doi.org/10.1016/J.JAD.2013.06.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAD.2013.06.049</ArticleId><ArticleId IdType="pubmed">23866302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhutada P, Mundhada Y, Bansod K et al (2010) Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice. Prog Neuro-Psychopharmacology Biol Psychiatry 34:955&#x2013;960. https://doi.org/10.1016/J.PNPBP.2010.04.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PNPBP.2010.04.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardianto C, Budiatin AS, Sumartha INB et al (2021) Resveratrol ameliorates physical and psychological stress-induced depressive-like behavior. J Basic Clin Physiol Pharmacol 32:335&#x2013;340. https://doi.org/10.1515/JBCPP-2020-0437/MACHINEREADABLECITATION/RIS</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/JBCPP-2020-0437/MACHINEREADABLECITATION/RIS</ArticleId><ArticleId IdType="pubmed">34214312</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bardeleben U, Holsboer F (1989) Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1:485&#x2013;488. https://doi.org/10.1111/J.1365-2826.1989.TB00150.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1365-2826.1989.TB00150.X</ArticleId><ArticleId IdType="pubmed">19210420</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng B, Xu Q, Liu J et al (2021) Corticosterone attenuates reward-seeking behavior and increases anxiety via D2 receptor signaling in ventral tegmental area dopamine neurons. J Neurosci 41:1566&#x2013;1581. https://doi.org/10.1523/JNEUROSCI.2533-20.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2533-20.2020</ArticleId><ArticleId IdType="pubmed">33372063</ArticleId><ArticleId IdType="pmc">7896015</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuirmeileh A, Lever R, Kingsbury AE et al (2007) The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson&#x2019;s disease. Eur J Neurosci 26:417&#x2013;423. https://doi.org/10.1111/J.1460-9568.2007.05653.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1460-9568.2007.05653.X</ArticleId><ArticleId IdType="pubmed">17650114</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroto-Escuela DO, Ambrogini P, Chru&#x15b;cicka B et al (2021) The role of central serotonin neurons and 5-HT heteroreceptor complexes in the pathophysiology of depression: a historical perspective and future prospects. Int J Mol Sci 1927(22):1927. https://doi.org/10.3390/IJMS22041927</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS22041927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327&#x2013;337. https://doi.org/10.1001/ARCHPSYC.64.3.327</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHPSYC.64.3.327</ArticleId><ArticleId IdType="pubmed">17339521</ArticleId></ArticleIdList></Reference><Reference><Citation>Karayol R, Medrihan L, Warner-Schmidt JL et al (2021) Serotonin receptor 4 in the hippocampus modulates mood and anxiety. Mol Psychiatry 266(26):2334&#x2013;2349. https://doi.org/10.1038/s41380-020-00994-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00994-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellen LC, Lewis MM, Du G et al (2021) Low plasma serotonin linked to higher nigral iron in Parkinson&#x2019;s disease. Sci Rep 111(11):1&#x2013;12. https://doi.org/10.1038/s41598-021-03700-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03700-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng ST, Le WX, Wang YT et al (2021) Efficacy of traditional chinese medicine combined with selective serotonin reuptake inhibitors on the treatment for Parkinson&#x2019;s disease with depression: a systematic review and meta-analysis. Am J Chin Med 49:627&#x2013;643. https://doi.org/10.1142/S0192415X21500282</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X21500282</ArticleId><ArticleId IdType="pubmed">33657988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MH, Moshahid Alam Rizvi M, Fatima M, Mondal AC (2021) Impact of NGF signaling on neuroplasticity during depression: insights in neuroplasticity-dependent therapeutic approaches. Neurosci Depress Genet Cell Biol Neurol Behav Diet 341&#x2013;350. https://doi.org/10.1016/B978-0-12-817935-2.00032-5</Citation></Reference><Reference><Citation>Tuszynski MH, Yang JH, Barba D et al (2015) Nerve growth factor gene therapy: activation of neuronal responses in Alzheimer disease. JAMA Neurol 72:1139&#x2013;1147. https://doi.org/10.1001/JAMANEUROL.2015.1807</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANEUROL.2015.1807</ArticleId><ArticleId IdType="pubmed">26302439</ArticleId><ArticleId IdType="pmc">4944824</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, Wu D, Qin M et al (2019) Efficient delivery of nerve growth factors to the central nervous system for neural regeneration. Adv Mater 31:1900727. https://doi.org/10.1002/ADMA.201900727</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ADMA.201900727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopach O, Pavlov AM, Sindeeva OA et al (2020) Biodegradable microcapsules loaded with nerve growth factor enable neurite guidance and synapse formation. Pharmaceutics 25(13):25. https://doi.org/10.3390/PHARMACEUTICS13010025</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/PHARMACEUTICS13010025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Li D, Wu C et al (2020) Nerve growth factor activates autophagy in Schwann cells to enhance myelin debris clearance and to expedite nerve regeneration. Theranostics 10:1649. https://doi.org/10.7150/THNO.40919</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/THNO.40919</ArticleId><ArticleId IdType="pubmed">32042328</ArticleId><ArticleId IdType="pmc">6993217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal AC, Fatima M (2019) Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment. Int J Neurosci 129:283&#x2013;296. https://doi.org/10.1080/00207454.2018.1527328</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2018.1527328</ArticleId><ArticleId IdType="pubmed">30235967</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Z, Zhang C, Yan L et al (2020) EPA is more effective than DHA to improve depression-like behavior, glia cell dysfunction and hippcampal apoptosis signaling in a chronic stress-induced rat model of depression. Int J Mol Sci 1769(21):1769. https://doi.org/10.3390/IJMS21051769</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS21051769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YW, Lin PY, Tu KY et al (2015) Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatr Dis Treat 11:925. https://doi.org/10.2147/NDT.S81432</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S81432</ArticleId><ArticleId IdType="pubmed">25897228</ArticleId><ArticleId IdType="pmc">4389916</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrotti Moreira F, Cardoso TC, Mondin TC et al (2019) Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder. Psychiatry Clin Neurosci 73:590&#x2013;593. https://doi.org/10.1111/PCN.12896</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/PCN.12896</ArticleId><ArticleId IdType="pubmed">31170316</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C, Farioli-Vecchioli S, Cisale GY et al (2021) A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. Curr Neuropharmacol 19:610&#x2013;628. https://doi.org/10.2174/1570159X18666200730111528</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X18666200730111528</ArticleId><ArticleId IdType="pubmed">32744976</ArticleId><ArticleId IdType="pmc">8573748</ArticleId></ArticleIdList></Reference><Reference><Citation>Konjevod M, Nikolac Perkovic M, S&#xe1;iz J et al (2021) Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases. J Pharm Biomed Anal 194:113681. https://doi.org/10.1016/J.JPBA.2020.113681</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JPBA.2020.113681</ArticleId><ArticleId IdType="pubmed">33279302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucidi L, Pettorruso M, Vellante F et al (2021) Gut microbiota and bipolar disorder: an overview on a novel biomarker for diagnosis and treatment. Int J Mol Sci 22. https://doi.org/10.3390/IJMS22073723</Citation></Reference><Reference><Citation>Kelly JR, Clarke G, Cryan JF, Dinan TG (2016) Brain-gut-microbiota axis: challenges for translation in psychiatry. Ann Epidemiol 26:366&#x2013;372. https://doi.org/10.1016/J.ANNEPIDEM.2016.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ANNEPIDEM.2016.02.008</ArticleId><ArticleId IdType="pubmed">27005587</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Bekhit AEDA, Wu Q et al (2021) Bioactive peptides and gut microbiota: candidates for a novel strategy for reduction and control of neurodegenerative diseases. Trends Food Sci Technol 108:164&#x2013;176. https://doi.org/10.1016/J.TIFS.2020.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TIFS.2020.12.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Agirman G, Yu KB, Hsiao EY (2021) Signaling inflammation across the gut-brain axis. Science 374:1087&#x2013;1092. https://doi.org/10.1126/SCIENCE.ABI6087/ASSET/810B821D-6005-435E-8F2D-953546DB4BF4/ASSETS/IMAGES/LARGE/SCIENCE.ABI6087-F2.JPG</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABI6087/ASSET/810B821D-6005-435E-8F2D-953546DB4BF4/ASSETS/IMAGES/LARGE/SCIENCE.ABI6087-F2.JPG</ArticleId><ArticleId IdType="pubmed">34822299</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais LH, Schreiber HL, Mazmanian SK (2020) The gut microbiota&#x2013;brain axis in behaviour and brain disorders. Nat Rev Microbiol 194(19):241&#x2013;255. https://doi.org/10.1038/s41579-020-00460-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00460-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayana P, Colpo GD, Sim&#xf5;es LR et al (2017) A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res 92:160&#x2013;182. https://doi.org/10.1016/J.JPSYCHIRES.2017.03.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JPSYCHIRES.2017.03.018</ArticleId><ArticleId IdType="pubmed">28458141</ArticleId></ArticleIdList></Reference><Reference><Citation>Naaldijk YM, Bittencourt MC, Sack U, Ulrich H (2016) Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis. Biol Chem 397:283&#x2013;296. https://doi.org/10.1515/HSZ-2015-0257/ASSET/GRAPHIC/J_HSZ-2015-0257_FIG_002.JPG</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/HSZ-2015-0257/ASSET/GRAPHIC/J_HSZ-2015-0257_FIG_002.JPG</ArticleId><ArticleId IdType="pubmed">26859499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gondalia S, Parkinson L, Stough C, Scholey A (2019) Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy. Psychopharmacol 2365(236):1433&#x2013;1443. https://doi.org/10.1007/S00213-019-05248-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00213-019-05248-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Painold A, M&#xf6;rkl S, Kashofer K et al (2019) A step ahead: exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. Bipolar Disord 21:40&#x2013;49. https://doi.org/10.1111/BDI.12682</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BDI.12682</ArticleId><ArticleId IdType="pubmed">30051546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunugi H (2021) Gut microbiota and pathophysiology of depressive disorder. Ann Nutr Metab 77:11&#x2013;20. https://doi.org/10.1159/000518274</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518274</ArticleId><ArticleId IdType="pubmed">34350881</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CR, Osadchiy V, Kalani A, Mayer EA (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6:133. https://doi.org/10.1016/J.JCMGH.2018.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JCMGH.2018.04.003</ArticleId><ArticleId IdType="pubmed">30023410</ArticleId><ArticleId IdType="pmc">6047317</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannone LF, Preda A, Blotti&#xe8;re HM et al (2019) Microbiota-gut brain axis involvement in neuropsychiatric disorders. Expert Rev Neurother 19:1037&#x2013;1050. https://doi.org/10.1080/14737175.2019.1638763</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2019.1638763</ArticleId><ArticleId IdType="pubmed">31260640</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Li F, Ke H et al (2022) Effect of metformin in autistic BTBR T+Itpr3tf/J Mice administered a high-fat diet. Brain Res Bull 183:172&#x2013;183. https://doi.org/10.1016/J.BRAINRESBULL.2022.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRESBULL.2022.02.021</ArticleId><ArticleId IdType="pubmed">35240246</ArticleId></ArticleIdList></Reference><Reference><Citation>Messias EL, Chen CY, Eaton WW (2007) Epidemiology of schizophrenia: review of findings and myths. Psychiatr Clin North Am 30:323. https://doi.org/10.1016/J.PSC.2007.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSC.2007.04.007</ArticleId><ArticleId IdType="pubmed">17720026</ArticleId><ArticleId IdType="pmc">2727721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang ZQ, Shen LL, Li WW et al (2018) Gut microbiota is altered in patients with Alzheimer&#x2019;s Disease. J Alzheimer&#x2019;s Dis 63:1337&#x2013;1346. https://doi.org/10.3233/JAD-180176</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Z, Zhu M, Liu X et al (2021) Fecal fungal dysbiosis in Chinese patients with Alzheimer&#x2019;s disease. Front cell Dev Biol 8. https://doi.org/10.3389/FCELL.2020.631460</Citation></Reference><Reference><Citation>Vogt NM, Kerby RL, Dill-McFarland KA et al (2017) Gut microbiome alterations in Alzheimer&#x2019;s disease. Sci Reports 71(7):1&#x2013;11. https://doi.org/10.1038/s41598-017-13601-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13601-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Harach T, Marungruang N, Duthilleul N et al (2017) Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Nat Publ Gr. https://doi.org/10.1038/srep41802</Citation></Reference><Reference><Citation>Fujii Y, Nguyen TTT, Fujimura Y et al (2019) Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer&#x2019;s disease. OUP 83:2144&#x2013;2152. https://doi.org/10.1080/09168451.2019.1644149</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09168451.2019.1644149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Jaber V, Lukiw WJ (2017) Secretory products of the human GI tract microbiome and their potential impact on Alzheimer&#x2019;s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol 7:268242. https://doi.org/10.3389/FCIMB.2017.00318/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCIMB.2017.00318/BIBTEX</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentsen T, Qian Y, Gkotzis S et al (2016) The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol Psychiatry 222(22):257&#x2013;266. https://doi.org/10.1038/mp.2016.182</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.182</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Mezzenga R (2019) Food protein amyloid fibrils: origin, structure, formation, characterization, applications and health implications. Adv Colloid Interface Sci 269:334&#x2013;356. https://doi.org/10.1016/J.CIS.2019.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CIS.2019.05.002</ArticleId><ArticleId IdType="pubmed">31128463</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RK, Chang HW, Yan D et al (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15:73. https://doi.org/10.1186/S12967-017-1175-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12967-017-1175-Y</ArticleId><ArticleId IdType="pubmed">28388917</ArticleId><ArticleId IdType="pmc">5385025</ArticleId></ArticleIdList></Reference><Reference><Citation>Rietdijk CD, Perez-Pardo P, Garssen J et al (2017) Exploring Braak&#x2019;s hypothesis of Parkinson&#x2019;s disease. Front Neurol 8:37. https://doi.org/10.3389/FNEUR.2017.00037/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2017.00037/BIBTEX</ArticleId><ArticleId IdType="pubmed">28243222</ArticleId><ArticleId IdType="pmc">5304413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfner F, K&#xfc;nstner A, M&#xfc;ller SH et al (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41&#x2013;45. https://doi.org/10.1016/J.BRAINRES.2017.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRES.2017.04.019</ArticleId><ArticleId IdType="pubmed">28506555</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F, Aho V, Pereira PAB et al (2015) Gut microbiota are related to Parkinson&#x2019;s disease and clinical phenotype. Mov Disord 30:350&#x2013;358. https://doi.org/10.1002/MDS.26069</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/MDS.26069</ArticleId><ArticleId IdType="pubmed">25476529</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson&#x2019;s disease. J Neurochem 139:216&#x2013;231. https://doi.org/10.1111/JNC.13731</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JNC.13731</ArticleId><ArticleId IdType="pubmed">27546335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Romero MDC, Arg&#xfc;elles S, Villar&#xe1;n RF et al (2008) Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. J Neurochem 105:445&#x2013;459. https://doi.org/10.1111/J.1471-4159.2007.05148.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1471-4159.2007.05148.X</ArticleId><ArticleId IdType="pubmed">18047562</ArticleId></ArticleIdList></Reference><Reference><Citation>Manole E, Dumitrescu L, Niculi&#x163;e CM, Popescu BO Potential roles of functional bacterial amyloid proteins, bacterial biosurfactants and other putative gut microbiota products in the etiopathogeny of Parkinson&#x2019;s Disease. https://doi.org/10.32604/biocell.2021.013452</Citation></Reference><Reference><Citation>Goldman SM, Kamel F, Ross GW et al (2014) Peptidoglycan recognition protein genes and risk of Parkinson&#x2019;s disease. Mov Disord 29:1171&#x2013;1180. https://doi.org/10.1002/MDS.25895</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/MDS.25895</ArticleId><ArticleId IdType="pubmed">24838182</ArticleId><ArticleId IdType="pmc">4777298</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasser CI, Mercieca EC, Kong G et al (2020) Gut dysbiosis in Huntington&#x2019;s disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Commun 2. https://doi.org/10.1093/BRAINCOMMS/FCAA110</Citation></Reference><Reference><Citation>Kong G, Cao KAL, Judd LM et al (2020) Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington&#x2019;s disease. Neurobiol Dis 135:104268. https://doi.org/10.1016/J.NBD.2018.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NBD.2018.09.001</ArticleId><ArticleId IdType="pubmed">30194046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P, Su L, Zhu H et al (2021) Gut microbiota regulation and their implication in the development of neurodegenerative disease. Microorg 2281(9):2281. https://doi.org/10.3390/MICROORGANISMS9112281</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MICROORGANISMS9112281</ArticleId></ArticleIdList></Reference><Reference><Citation>Radulescu CI, Garcia-Miralles M, Sidik H et al (2020) Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease. Neurobiol Dis 135:104744. https://doi.org/10.1016/J.NBD.2020.104744</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NBD.2020.104744</ArticleId><ArticleId IdType="pubmed">31931139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho ZY, Lal SK (2018) The human gut microbiome - a potential controller of wellness and disease. Front Microbiol 9:1835. https://doi.org/10.3389/FMICB.2018.01835/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2018.01835/BIBTEX</ArticleId><ArticleId IdType="pubmed">30154767</ArticleId><ArticleId IdType="pmc">6102370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, Zhang T, Park S (2022) Protective effects of Forsythiae fructus and Cassiae semen water extract against memory deficits through the gut-microbiome-brain axis in an Alzheimer&#x2019;s disease model. Pharm Biol 60:212. https://doi.org/10.1080/13880209.2022.2025860</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13880209.2022.2025860</ArticleId><ArticleId IdType="pubmed">35076339</ArticleId><ArticleId IdType="pmc">8794073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Feng B-N, Hu B et al (2022) Neuroprotection of chicoric acid in a mouse model of Parkinson&#x2019;s disease involves gut microbiota and TLR4 signaling pathway. Food Funct 13:2019&#x2013;2032. https://doi.org/10.1039/D1FO02216D</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1FO02216D</ArticleId><ArticleId IdType="pubmed">35103734</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Liu Z, Dong X et al (2018) Fecal microbiota transplantation from healthy donors reduced alcohol-induced anxiety and depression in an animal model of chronic alcohol exposure. Chin J Physiol 61:360&#x2013;371. https://doi.org/10.4077/CJP.2018.BAH633</Citation><ArticleIdList><ArticleId IdType="doi">10.4077/CJP.2018.BAH633</ArticleId><ArticleId IdType="pubmed">30580506</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclercq S, Le Roy T, Furgiuele S et al (2020) Gut microbiota-induced changes in &#x3b2;-hydroxybutyrate metabolism are linked to altered sociability and depression in alcohol use disorder. Cell Rep 33:108238. https://doi.org/10.1016/J.CELREP.2020.108238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELREP.2020.108238</ArticleId><ArticleId IdType="pubmed">33053357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu P, Wang D, Zhang Y et al (2020) Apoptosis-triggered decline in hippocampal microglia mediates adolescent intermittent alcohol exposure-induced depression-like behaviors in mice. Neuropharmacology 170:108054. https://doi.org/10.1016/J.NEUROPHARM.2020.108054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROPHARM.2020.108054</ArticleId><ArticleId IdType="pubmed">32217088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen XH, Ge C, Xing FG et al (2018) Gut microbiota modulates alcohol withdrawal-induced anxiety in mice. Toxicol Lett 287:23&#x2013;30. https://doi.org/10.1016/J.TOXLET.2018.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TOXLET.2018.01.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferragud A, Velazquez-Sanchez C, Minnig MA et al (2020) Pituitary adenylate cyclase-activating polypeptide (PACAP) modulates dependence-induced alcohol drinking and anxiety-like behavior in male rats. Neuropsychopharmacol 463(46):509&#x2013;518. https://doi.org/10.1038/s41386-020-00904-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-020-00904-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielenz D, Reichel M, Jia T et al (2018) EFhd2/Swiprosin-1 is a common genetic determinator for sensation-seeking/low anxiety and alcohol addiction. Mol Psychiatry 235(23):1303&#x2013;1319. https://doi.org/10.1038/mp.2017.63</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2017.63</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JL, Gonzalez Pini VM, Messore FL, Brusco A (2018) Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice. Neuropharmacology 137:268&#x2013;274. https://doi.org/10.1016/J.NEUROPHARM.2018.05.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROPHARM.2018.05.018</ArticleId><ArticleId IdType="pubmed">29778010</ArticleId></ArticleIdList></Reference><Reference><Citation>Le&#xf3;n BE, Kang S, Franca-Solomon G et al (2021) Alcohol-Induced neuroinflammatory response and mitochondrial dysfunction on aging and Alzheimer&#x2019;s disease. Front Behav Neurosci 15. https://doi.org/10.3389/FNBEH.2021.778456</Citation></Reference><Reference><Citation>Hoffman JL, Faccidomo S, Kim M et al (2019) Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer&#x2019;s disease. Int Rev Neurobiol 148:169&#x2013;230. https://doi.org/10.1016/BS.IRN.2019.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/BS.IRN.2019.10.017</ArticleId><ArticleId IdType="pubmed">31733664</ArticleId><ArticleId IdType="pmc">6939615</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez-Jim&#xe9;nez FJ, Alonso-Navarro H, Garc&#xed;a-Mart&#xed;n E, Ag&#xfa;ndez JAG (2019) Alcohol consumption and risk for Parkinson&#x2019;s disease: a systematic review and meta-analysis. J Neurol 266:1821&#x2013;1834. https://doi.org/10.1007/S00415-018-9032-3/FIGURES/5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00415-018-9032-3/FIGURES/5</ArticleId><ArticleId IdType="pubmed">30155737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A, Giese KP (2015) Calcium/calmodulin-dependent kinase II and Alzheimer&#x2019;s disease. Mol Brain 8:1&#x2013;7. https://doi.org/10.1186/S13041-015-0166-2/FIGURES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13041-015-0166-2/FIGURES/1</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison AJ (2014) Emerging role of CaMKII in neuropsychiatric disease. Trends Neurosci 37:653&#x2013;662. https://doi.org/10.1016/J.TINS.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TINS.2014.07.001</ArticleId><ArticleId IdType="pubmed">25087161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Groth RD, Cohen SM et al (2014) &#x3b3;CaMKII Shuttles Ca2+/CaM to the nucleus to trigger CREB phosphorylation and gene expression. Cell 159:281&#x2013;294. https://doi.org/10.1016/J.CELL.2014.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2014.09.019</ArticleId><ArticleId IdType="pubmed">25303525</ArticleId><ArticleId IdType="pmc">4201038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Mart&#xed;nez S (2015) A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis. Front Mol Neurosci 8:46. https://doi.org/10.3389/FNMOL.2015.00046/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNMOL.2015.00046/BIBTEX</ArticleId><ArticleId IdType="pubmed">26379491</ArticleId><ArticleId IdType="pmc">4549561</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SM (2016) Signaling to the nucleus in excitatory and inhibitory neurons (Order No. 10139606). Available from Publicly Available Content Database. (1820070931). Retrieved from https://www.proquest.com/dissertations-theses/signaling-nucleus-excitatory-inhibitory-neurons/docview/1820070931/se-2</Citation></Reference><Reference><Citation>Zamarbide M, Mossa A, Mu&#xf1;oz-Llancao P et al (2019) Male-specific cAMP signaling in the hippocampus controls spatial memory deficits in a mouse model of autism and intellectual disability. Biol Psychiatry 85:760&#x2013;768. https://doi.org/10.1016/J.BIOPSYCH.2018.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BIOPSYCH.2018.12.013</ArticleId><ArticleId IdType="pubmed">30732858</ArticleId></ArticleIdList></Reference><Reference><Citation>Androschuk A, Al-Jabri B, Bolduc FV (2015) From learning to memory: what flies can tell us about intellectual disability treatment. Front Psychiatry 6:85. https://doi.org/10.3389/FPSYT.2015.00085/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPSYT.2015.00085/BIBTEX</ArticleId><ArticleId IdType="pubmed">26089803</ArticleId><ArticleId IdType="pmc">4453272</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza MA, Magni DV, Guerra GP et al (2012) Involvement of hippocampal CAMKII/CREB signaling in the spatial memory retention induced by creatine. Amino Acids 43:2491&#x2013;2503. https://doi.org/10.1007/S00726-012-1329-4/TABLES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00726-012-1329-4/TABLES/2</ArticleId><ArticleId IdType="pubmed">22669403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Liu R, Zhang J et al (2021) Electroacupuncture ameliorates depression-like behaviour in rats by enhancing synaptic plasticity via the GluN2B/CaMKII/ CREB signalling pathway. Evidence-Based Complement Altern Med 2021. https://doi.org/10.1155/2021/2146001</Citation></Reference><Reference><Citation>Misrani A, Tabassum S, Wang M et al (2020) Citalopram prevents sleep-deprivation-induced reduction in CaMKII-CREB-BDNF signaling in mouse prefrontal cortex. Brain Res Bull 155:11&#x2013;18. https://doi.org/10.1016/J.BRAINRESBULL.2019.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRESBULL.2019.11.007</ArticleId><ArticleId IdType="pubmed">31743748</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam R, Matsuzaki K, Sumiyoshi E et al (2019) Theobromine improves working memory by activating the CaMKII/CREB/BDNF pathway in rats. Nutr 888(11):888. https://doi.org/10.3390/NU11040888</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/NU11040888</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, Yang L, Wei W (2021) Role of Fto on CaMKII/CREB signaling pathway of hippocampus in depressive-like behaviors induced by chronic restraint stress mice. Behav Brain Res 406:113227. https://doi.org/10.1016/J.BBR.2021.113227</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2021.113227</ArticleId><ArticleId IdType="pubmed">33677012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu ZM, Ni GL, Shao AM, Cui R (2017) Genistein alleviates anxiety-like behaviors in post-traumatic stress disorder model through enhancing serotonergic transmission in the amygdala. Psychiatry Res 255:287&#x2013;291. https://doi.org/10.1016/J.PSYCHRES.2017.05.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSYCHRES.2017.05.051</ArticleId><ArticleId IdType="pubmed">28600997</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XL, Deng YX, Gao YM et al (2020) Activation of &#x3b1;7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway. Aging (Albany NY) 12:543. https://doi.org/10.18632/AGING.102640</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/AGING.102640</ArticleId><ArticleId IdType="pubmed">31905173</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie W, Meng X, Zhai Y et al (2019) Antidepressant-like effects of the Guanxin Danshen formula via mediation of the CaMK II-CREB-BDNF signalling pathway in chronic unpredictable mild stress-induced depressive rats. Ann Transl Med 7:564&#x2013;564. https://doi.org/10.21037/ATM.2019.09.39</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/ATM.2019.09.39</ArticleId><ArticleId IdType="pubmed">31807545</ArticleId><ArticleId IdType="pmc">6861747</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Cui Z, He J et al (2021) &#x3ba;-opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca2+/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice. Mol Med Rep 24:1&#x2013;9. https://doi.org/10.3892/MMR.2021.12168/HTML</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/MMR.2021.12168/HTML</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini F, R&#xe9;gis Leite M, Gon&#xe7;alves Rosa S et al (2020) Strength exercise suppresses STZ-induced spatial memory impairment and modulates BDNF/ERK-CAMKII/CREB signalling pathway in the hippocampus of mice. Cell Biochem Funct 38:213&#x2013;221. https://doi.org/10.1002/CBF.3470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/CBF.3470</ArticleId><ArticleId IdType="pubmed">31978253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Yu H, Huang C et al (2018) Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress. Redox Biol 16:47&#x2013;58. https://doi.org/10.1016/J.REDOX.2018.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.REDOX.2018.02.008</ArticleId><ArticleId IdType="pubmed">29475134</ArticleId><ArticleId IdType="pmc">5842311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilge SS, G&#xfc;naydin C, &#xd6;nger ME et al (2020) Neuroprotective action of agmatine in rotenone-induced model of Parkinson&#x2019;s disease: role of BDNF/cREB and ERK pathway. Behav Brain Res 392:112692. https://doi.org/10.1016/J.BBR.2020.112692</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2020.112692</ArticleId><ArticleId IdType="pubmed">32479847</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Wang Y, Mo M et al (2019) Minocycline protects against rotenone-induced neurotoxicity correlating with upregulation of Nurr1 in a Parkinson&#x2019;s disease rat model. Biomed Res Int 2019. https://doi.org/10.1155/2019/6843265</Citation></Reference><Reference><Citation>Song Y, Zhao X, Wang D et al (2019) Inhibition of LPS-induced brain injury by NR2B antagonists through reducing assembly of NR2B&#x2013;CaMKII&#x2013;PSD95 signal module. Immunopharmacol Immunotoxicol 41:86&#x2013;94. https://doi.org/10.1080/08923973.2018.1549566</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08923973.2018.1549566</ArticleId><ArticleId IdType="pubmed">30604645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning B, Zhang Q, Wang N et al (2019) &#x3b2;-Asarone regulates ER stress and autophagy via inhibition of the PERK/CHOP/Bcl-2/Beclin-1 pathway in 6-OHDA-induced Parkinsonian rats. Neurochem Res 44:1159&#x2013;1166. https://doi.org/10.1007/S11064-019-02757-W/TABLES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11064-019-02757-W/TABLES/1</ArticleId><ArticleId IdType="pubmed">30796752</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina JH, Viola H (2018) ERK1/2: a key cellular component for the formation, retrieval, reconsolidation and persistence of memory. Front Mol Neurosci 11:361. https://doi.org/10.3389/FNMOL.2018.00361/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNMOL.2018.00361/BIBTEX</ArticleId><ArticleId IdType="pubmed">30344477</ArticleId><ArticleId IdType="pmc">6182090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons MR, West AE (2011) Mechanisms of specificity in neuronal activity-regulated gene transcription. Prog Neurobiol 94:259. https://doi.org/10.1016/J.PNEUROBIO.2011.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PNEUROBIO.2011.05.003</ArticleId><ArticleId IdType="pubmed">21620929</ArticleId><ArticleId IdType="pmc">3134613</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgarejo da Rosa M, Yuanxiang PA, Brambilla R et al (2016) Synaptic GluN2B/CaMKII-&#x3b1; signaling induces synapto-nuclear transport of ERK and Jacob. Front Mol Neurosci 9:66. https://doi.org/10.3389/FNMOL.2016.00066/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNMOL.2016.00066/BIBTEX</ArticleId><ArticleId IdType="pubmed">27559307</ArticleId><ArticleId IdType="pmc">4978723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko MJ, Chiang T, Mukadam AA et al (2021) &#x3b2;-arrestin&#x2013;dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice. Sci Signal 14. https://doi.org/10.1126/SCISIGNAL.ABA0245</Citation></Reference><Reference><Citation>Sun S, Zhou J, Li Z et al (2022) Progranulin promotes hippocampal neurogenesis and alleviates anxiety-like behavior and cognitive impairment in adult mice subjected to cerebral ischemia. CNS Neurosci Ther. https://doi.org/10.1111/CNS.13810</Citation></Reference><Reference><Citation>Chuang HW, Wang TY, Huang CC, Wei IH (2022) Echinacoside exhibits antidepressant-like effects through AMPAR&#x2013;Akt/ERK&#x2013;mTOR pathway stimulation and BDNF expression in mice. Chinese Med (United Kingdom) 17:1&#x2013;12. https://doi.org/10.1186/S13020-021-00549-5/FIGURES/6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13020-021-00549-5/FIGURES/6</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Jia L, Shi D et al (2022) Deep brain stimulation improved depressive-like behaviors and hippocampal synapse deficits by activating the BDNF/mTOR signaling pathway. Behav Brain Res 419:113709. https://doi.org/10.1016/J.BBR.2021.113709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2021.113709</ArticleId><ArticleId IdType="pubmed">34890598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma QL, Harris-White ME, Ubeda OJ et al (2007) Evidence of A&#x3b2;- and transgene-dependent defects in ERK-CREB signaling in Alzheimer&#x2019;s models. J Neurochem 103:1594&#x2013;1607. https://doi.org/10.1111/J.1471-4159.2007.04869.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1471-4159.2007.04869.X</ArticleId><ArticleId IdType="pubmed">17760871</ArticleId><ArticleId IdType="pmc">2527620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Qin L, Huang F et al (2017) Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson&#x2019;s disease model mice through PI3K/Akt and ERK signaling pathways. Toxicol Appl Pharmacol 319:80&#x2013;90. https://doi.org/10.1016/J.TAAP.2017.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TAAP.2017.01.019</ArticleId><ArticleId IdType="pubmed">28185818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohush A, Niewiadomska G, Filipek A (2018) Role of mitogen activated protein kinase signaling in Parkinson&#x2019;s disease. Int J Mol Sci 2973(19):2973. https://doi.org/10.3390/IJMS19102973</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS19102973</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuf IO, Chen HM, Cheng PH et al (2019) Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington&#x2019;s disease. Free Radic Biol Med 130:256&#x2013;266. https://doi.org/10.1016/J.FREERADBIOMED.2018.10.455</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.FREERADBIOMED.2018.10.455</ArticleId><ArticleId IdType="pubmed">30391672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai SN, Dilnashin H, Birla H et al (2019) The role of PI3K/Akt and ERK in neurodegenerative disorders. Neurotox Res 353(35):775&#x2013;795. https://doi.org/10.1007/S12640-019-0003-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12640-019-0003-Y</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan X, Huang S, Wu L et al (2014) Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer&#x2019;s disease cybrid cell. Biochim Biophys Acta - Mol Basis Dis 1842:220&#x2013;231. https://doi.org/10.1016/J.BBADIS.2013.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBADIS.2013.11.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini E, Heiman M, Greengard P et al (2009) Inhibition of mTOR signaling in Parkinson&#x2019;s disease prevents L-DOPA-induced dyskinesia. Sci Signal 2. https://doi.org/10.1126/SCISIGNAL.2000308/SUPPL_FILE/2_RA36_SM.PDF</Citation></Reference><Reference><Citation>Maher P, Dargusch R, Bodai L et al (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington&#x2019;s disease. Hum Mol Genet 20:261&#x2013;270. https://doi.org/10.1093/HMG/DDQ460</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/HMG/DDQ460</ArticleId><ArticleId IdType="pubmed">20952447</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaver M, Bhatnagar A, Panikker P et al (2020) Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases. Sci Rep 10. https://doi.org/10.1038/s41598-020-75035-3</Citation></Reference><Reference><Citation>Esteves AR, Palma AM, Gomes R et al (2019) Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer&#x2019;s and Parkinson disease pathology. Biochim Biophys Acta - Mol Basis Dis. https://doi.org/10.1016/j.bbadis.2018.11.014</Citation></Reference><Reference><Citation>Beaver M, Karisetty BC, Zhang H et al (2021) Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT/HDAC2 epigenomic landscape in the neurodegenerative brain. Epigenetics. https://doi.org/10.1080/15592294.2021.1959742</Citation></Reference><Reference><Citation>Leite JA, Ghirotto B, Targhetta VP et al (2022) Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders. Br J Pharmacol 179:1496&#x2013;1511</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15570</ArticleId><ArticleId IdType="pubmed">34029375</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjula R, Anuja K, Alcain FJ (2021) SIRT1 and SIRT2 activity control in neurodegenerative diseases. Front Pharmacol 11</Citation></Reference><Reference><Citation>Zhang H, Karisetty BC, Bhatnagar A et al (2020) Tip60 protects against amyloid-&#x3b2;-induced transcriptomic alterations via different modes of action in early versus late stages of neurodegeneration. Mol Cell Neurosci 109. https://doi.org/10.1016/j.mcn.2020.103570</Citation></Reference><Reference><Citation>Takasu K, Niidome K, Hasegawa M, Ogawa K (2021) Histone deacetylase inhibitor improves the dysfunction of hippocampal gamma oscillations and fast spiking interneurons in Alzheimer&#x2019;s disease model mice. Front Mol Neurosci 14. https://doi.org/10.3389/fnmol.2021.782206</Citation></Reference><Reference><Citation>Mazzocchi M, Goulding SR, Wyatt SL et al (2021) LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and &#x3b1;-synuclein-induced degeneration in cellular models of Parkinson&#x2019;s disease. Mol Cell Neurosci 115:103642. https://doi.org/10.1016/J.MCN.2021.103642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MCN.2021.103642</ArticleId><ArticleId IdType="pubmed">34119632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzocchi M, Goulding SR, Morales-Prieto N et al (2022) Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson&#x2019;s disease. Brain Behav Immun 102:151&#x2013;160. https://doi.org/10.1016/j.bbi.2022.02.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.02.025</ArticleId><ArticleId IdType="pubmed">35217173</ArticleId></ArticleIdList></Reference><Reference><Citation>Burg T, Rossaert E, Moisse M et al (2021) Histone deacetylase inhibition regulates lipid homeostasis in a mouse model of amyotrophic lateral sclerosis. Int J Mol Sci 22. https://doi.org/10.3390/ijms222011224</Citation></Reference><Reference><Citation>Rossaert E, Pollari E, Jaspers T et al (2019) Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun 7:107. https://doi.org/10.1186/s40478-019-0750-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0750-2</ArticleId><ArticleId IdType="pubmed">31277703</ArticleId><ArticleId IdType="pmc">6612190</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigna E, Simonazzi E, Sanna K et al (2019) Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40:717&#x2013;732. https://doi.org/10.1016/j.ebiom.2019.01.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.01.038</ArticleId><ArticleId IdType="pubmed">30713114</ArticleId><ArticleId IdType="pmc">6414308</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, Krasnow EN, Fumagalli L et al (2021) Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Reports 16:2213&#x2013;2227. https://doi.org/10.1016/j.stemcr.2021.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.029</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId><ArticleId IdType="pmc">8452598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecklau K, Mueller S, Koch SP et al (2021) The effects of selective inhibition of histone deacetylase 1 and 3 in Huntington&#x2019;s disease Mice. Front Mol Neurosci 14. https://doi.org/10.3389/fnmol.2021.616886</Citation></Reference><Reference><Citation>Gilbert TM, Z&#xfc;rcher NR, Wu CJ et al (2019) PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia. J Clin Invest 129. https://doi.org/10.1172/JCI123743</Citation></Reference><Reference><Citation>Ibi D, De La Fuente RM, Kezunovic N et al (2017) Antipsychotic-induced Hdac2 transcription via NF-&#x3ba;B leads to synaptic and cognitive side effects. Nat Neurosci 20:1247&#x2013;1259. https://doi.org/10.1038/nn.4616</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4616</ArticleId><ArticleId IdType="pubmed">28783139</ArticleId><ArticleId IdType="pmc">5675106</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Fuente RM, Ibi D, Saunders JM et al (2018) HDAC2-dependent antipsychotic-like effects of chronic treatment with the HDAC inhibitor SAHA in mice. Neuroscience 388:102&#x2013;117. https://doi.org/10.1016/j.neuroscience.2018.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng CEJ, Gilbert TM, Catanese MC et al (2020) In vivo human brain expression of histone deacetylases in bipolar disorder. Transl Psychiatry 10. https://doi.org/10.1038/s41398-020-00911-5</Citation></Reference><Reference><Citation>Iaconelli J, Xuan L, Karmacharya R (2019) HDAC6 modulates signaling pathways relevant to synaptic biology and neuronal differentiation in human stem cell-derived neurons. Int J Mol Sci 20</Citation></Reference><Reference><Citation>Qin L, Ma K, Yan Z (2021) Rescue of histone hypoacetylation and social deficits by ketogenic diet in a Shank3 mouse model of autism. Neuropsychopharmacology 47(6):1271&#x2013;1279</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-01212-1</ArticleId><ArticleId IdType="pubmed">34703011</ArticleId><ArticleId IdType="pmc">9018860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma K, Qin L, Matas E et al (2018) Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism. Neuropsychopharmacology 43:1779&#x2013;1788</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-018-0073-1</ArticleId><ArticleId IdType="pubmed">29760409</ArticleId><ArticleId IdType="pmc">6006368</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Ma K, Wang ZJ et al (2018) Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition. Nat Neurosci 21:564&#x2013;575. https://doi.org/10.1038/s41593-018-0110-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0110-8</ArticleId><ArticleId IdType="pubmed">29531362</ArticleId><ArticleId IdType="pmc">5876144</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Tan M, Cheng B et al (2021) Valproic acid induces autism-like synaptic and behavioral deficits by disrupting histone acetylation of prefrontal cortex ALDH1A1 in rats. Front Neurosci 15. https://doi.org/10.3389/fnins.2021.641284</Citation></Reference><Reference><Citation>Basu T, O&#x2019;Riordan KJ, Schoenike BA et al (2019) Histone deacetylase inhibitors restore normal hippocampal synaptic plasticity and seizure threshold in a mouse model of Tuberous Sclerosis Complex. Sci Rep 9. https://doi.org/10.1038/s41598-019-41744-7</Citation></Reference><Reference><Citation>Mishra R, Amanullah A, Upadhyay A et al (2020) Ubiquitin ligase LRSAM1 suppresses neurodegenerative diseases linked aberrant proteins induced cell death. Int J Biochem Cell Biol 120. https://doi.org/10.1016/j.biocel.2020.105697</Citation></Reference><Reference><Citation>Potjewyd FM, Axtman AD (2021) Exploration of aberrant E3 ligases implicated in Alzheimer&#x2019;s disease and development of chemical tools to modulate their function. Front Cell Neurosci 15</Citation></Reference><Reference><Citation>Wang XL, Feng ST, Wang ZZ et al (2021) Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control in Parkinson&#x2019;s disease. Cell Mol Neurobiol 41:1395&#x2013;1411</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00914-2</ArticleId><ArticleId IdType="pubmed">32623547</ArticleId></ArticleIdList></Reference><Reference><Citation>Watabe K, Kato Y, Sakuma M et al (2020) Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation. Neuropathology 40:570&#x2013;586. https://doi.org/10.1111/neup.12694</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12694</ArticleId><ArticleId IdType="pubmed">32686212</ArticleId><ArticleId IdType="pmc">7818255</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen S, van der Werf IM, Innes AM et al (2019) De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms. Eur J Hum Genet 27:738&#x2013;746. https://doi.org/10.1038/s41431-018-0292-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0292-2</ArticleId><ArticleId IdType="pubmed">30679813</ArticleId><ArticleId IdType="pmc">6462006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapanelli M, Tan T, Wang W et al (2021) Behavioral, circuitry, and molecular aberrations by region-specific deficiency of the high-risk autism gene Cul3. Mol Psychiatry 26:1491&#x2013;1504. https://doi.org/10.1038/s41380-019-0498-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0498-x</ArticleId><ArticleId IdType="pubmed">31455858</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar M, Pramod AB, Yu NK et al (2021) Autism-linked Cullin3 germline haploinsufficiency impacts cytoskeletal dynamics and cortical neurogenesis through RhoA signaling. Mol Psychiatry 26:3586&#x2013;3613. https://doi.org/10.1038/s41380-021-01052-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01052-x</ArticleId><ArticleId IdType="pubmed">33727673</ArticleId><ArticleId IdType="pmc">8443683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohlbrenner EA, Shaskan N, Pietersen CY et al (2018) Gene expression profile associated with postnatal development of pyramidal neurons in the human prefrontal cortex implicates ubiquitin ligase E3 in the pathophysiology of schizophrenia onset. J Psychiatr Res 102:110&#x2013;117. https://doi.org/10.1016/j.jpsychires.2018.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2018.03.013</ArticleId><ArticleId IdType="pubmed">29635114</ArticleId><ArticleId IdType="pmc">6347389</ArticleId></ArticleIdList></Reference><Reference><Citation>Strohmeyer R, Shelton J, Lougheed C, Breitkopf T (2014) CCAAT-enhancer binding protein-&#x3b2; expression and elevation in Alzheimer&#x2019;s disease and microglial cell cultures. PLoS One 9. https://doi.org/10.1371/journal.pone.0086617</Citation></Reference><Reference><Citation>Ndoja A, Reja R, Lee SH et al (2020) Ubiquitin ligase COP1 Suppresses neuroinflammation by degrading c/EBP&#x3b2; in microglia. Cell 182:1156&#x2013;1169.e12</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.011</ArticleId><ArticleId IdType="pubmed">32795415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung E, Choi Y, Park J et al (2020) Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological &#x3b1;-synuclein. Sci Adv 6</Citation></Reference><Reference><Citation>Weskamp K, Barmada SJ (2018) TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res 1693:67&#x2013;74</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.01.015</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId><ArticleId IdType="pmc">5997512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P, Li Y, Wang H, Mao B (2021) Haploinsufficiency of the TDP43 ubiquitin E3 ligase RNF220 leads to ALS-like motor neuron defects in the mouse. J Mol Cell Biol 13:374&#x2013;382. https://doi.org/10.1093/jmcb/mjaa072</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjaa072</ArticleId><ArticleId IdType="pubmed">33386850</ArticleId><ArticleId IdType="pmc">8373269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YC, Huang WC, Lin JH et al (2018) Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology 11 Medical and Health Sciences. J Biomed Sci 25. https://doi.org/10.1186/s12929-018-0479-4</Citation></Reference><Reference><Citation>Koyuncu S, Saez I, Lee HJ et al (2018) The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington&#x2019;s disease patients. Nat Commun 9. https://doi.org/10.1038/s41467-018-05320-3</Citation></Reference><Reference><Citation>Yang G, Wan P, Xiang Q et al (2021) E3 ubiquitin ligase ASB17 promotes apoptosis by ubiquitylating and degrading BCLW and MCL1. Biology (Basel) 10. https://doi.org/10.3390/biology10030234</Citation></Reference><Reference><Citation>Farhang S, Sabaie H, Gharesouran J et al (2022) Expression analysis of ermin and listerin E3 ubiquitin protein ligase 1 genes in the periphery of patients with schizophrenia. J Mol Neurosci 72:246&#x2013;254</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-021-01928-1</ArticleId><ArticleId IdType="pubmed">34676516</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiva S, Gharesouran J, Sabaie H et al (2021) Expression analysis of ermin and listerin E3 ubiquitin protein ligase 1 genes in autistic patients. Front Mol Neurosci 14. https://doi.org/10.3389/fnmol.2021.701977</Citation></Reference><Reference><Citation>Bi X, Cui K, Han C et al (2015) Association of NEDD4 gene polymorphisms with schizophrenia and its clinical characteristics in Chinese Han population. Chinese J Med Genet 32:385&#x2013;390</Citation></Reference><Reference><Citation>Han C, Cui K, Bi X et al (2019) Association between polymorphism of the NEDD4 gene and cognitive dysfunction of schizophrenia patients in Chinese Han population. BMC Psychiatry 19. https://doi.org/10.1186/s12888-019-2386-y</Citation></Reference><Reference><Citation>Wang W, Qiao Y, Qu H et al (2020) The protective role of Neuregulin1-ErbB4 signaling in a chronic social defeat stress model. Neuroreport 678&#x2013;685. https://doi.org/10.1097/WNR.0000000000001464</Citation></Reference><Reference><Citation>Xu J, Guo C, Liu Y et al (2020) Nedd4l downregulation of NRG1 in the mPFC induces depression-like behaviour in CSDS mice. Transl Psychiatry 10. https://doi.org/10.1038/s41398-020-00935-x</Citation></Reference><Reference><Citation>Kim S, Zhang S, Choi KH et al (2009) An E3 ubiquitin ligase, really interesting new gene (RING) finger 41, is a candidate gene for anxiety-like behavior and &#x3b2;-carboline-induced seizures. Biol Psychiatry 65:425&#x2013;431. https://doi.org/10.1016/j.biopsych.2008.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2008.09.015</ArticleId><ArticleId IdType="pubmed">18986647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez SJ, Segal DJ, LaSalle JM (2019) UBE3A: an E3 ubiquitin ligase with genome-wide impact in neurodevelopmental disease. Front Mol Neurosci 11</Citation></Reference><Reference><Citation>Yi JJ, Paranjape SR, Walker MP et al (2017) The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/&#x3b2;-catenin pathway by inhibiting the proteasome. J Biol Chem 292:12503&#x2013;12515. https://doi.org/10.1074/jbc.M117.788448</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.788448</ArticleId><ArticleId IdType="pubmed">28559284</ArticleId><ArticleId IdType="pmc">5535025</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z, Chen W, Chen C et al (2020) CUL3 deficiency causes social deficits and anxiety-like behaviors by impairing excitation-inhibition balance through the promotion of Cap-dependent translation. Neuron 105:475&#x2013;490.e6. https://doi.org/10.1016/j.neuron.2019.10.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.10.035</ArticleId><ArticleId IdType="pubmed">31780330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Rathod SSS, Ghoneim MM et al (2022) DNA methylation: a promising approach in management of Alzheimer&#x2019;s disease and other neurodegenerative disorders. Biology (Basel) 11</Citation></Reference><Reference><Citation>Bayer C, Pitschelatow G, Hannemann N et al (2020) DNA methyltransferase 1 (DNMT1) acts on neurodegeneration by modulating proteostasis-relevant intracellular processes. Int J Mol Sci 21:1&#x2013;18. https://doi.org/10.3390/ijms21155420</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155420</ArticleId></ArticleIdList></Reference><Reference><Citation>Zsindely N, Si&#xe1;gi F, Bodai L (2021) DNA methylation in huntington&#x2019;s disease. Int J Mol Sci 22</Citation></Reference><Reference><Citation>Tenorio J, Alarc&#xf3;n P, Arias P et al (2020) Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients. Eur J Hum Genet 28:469&#x2013;479. https://doi.org/10.1038/s41431-019-0485-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-019-0485-3</ArticleId><ArticleId IdType="pubmed">31685998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang B, Zeng B et al (2018) Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia. Schizophr Res 199:214&#x2013;220. https://doi.org/10.1016/j.schres.2018.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2018.04.023</ArticleId><ArticleId IdType="pubmed">29730044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HQ, Wang JY, Li ZF et al (2021) DNA Methyltransferase 1 is dysregulated in Parkinson&#x2019;s disease via mediation of miR-17. Mol Neurobiol 58:2620&#x2013;2633. https://doi.org/10.1007/s12035-021-02298-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02298-w</ArticleId><ArticleId IdType="pubmed">33483902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali CP, Park DS, Lee EB (2019) Targeted DNA methylation of neurodegenerative disease genes via homology directed repair. Nucleic Acids Res 47:11609&#x2013;11622. https://doi.org/10.1093/nar/gkz979</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz979</ArticleId><ArticleId IdType="pubmed">31680172</ArticleId><ArticleId IdType="pmc">7145628</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Daito T, Sasaki Y et al (2016) Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity. Sci Rep 6. https://doi.org/10.1038/srep31022</Citation></Reference><Reference><Citation>Alex AM, Saradalekshmi KR, Shilen N et al (2019) Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism. IUBMB Life 71:901&#x2013;907. https://doi.org/10.1002/iub.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2021</ArticleId><ArticleId IdType="pubmed">30786140</ArticleId></ArticleIdList></Reference><Reference><Citation>Christian DL, Wu DY, Martin JR et al (2020) DNMT3A Haploinsufficiency results in behavioral deficits and global epigenomic dysregulation shared across neurodevelopmental disorders. Cell Rep 33. https://doi.org/10.1016/j.celrep.2020.108416</Citation></Reference><Reference><Citation>Cui HZ, Sun MZ, Wang RZ et al (2020) DNA methylation in the medial prefrontal cortex regulates alcohol-related behavior in rats. Yi Chuan = Hered 42:112&#x2013;125. https://doi.org/10.16288/j.yczz.19-261</Citation><ArticleIdList><ArticleId IdType="doi">10.16288/j.yczz.19-261</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Addario C, Palazzo MC, Benatti B et al (2018) Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor. Prog Neuro-Psychopharmacology Biol Psychiatry 82:314&#x2013;321. https://doi.org/10.1016/j.pnpbp.2017.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2017.08.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Pang B, Zhang W et al (2018) Association between schizophrenia and DNA demethylase activity in human peripheral blood mononuclear cells. Clin Lab 64:1031&#x2013;1035. https://doi.org/10.7754/Clin.Lab.2018.180127</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2018.180127</ArticleId><ArticleId IdType="pubmed">29945331</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Choudhury S, Maroju PA et al (2021) Dysregulation of schizophrenia-Associated genes and genome-wide hypomethylation in neurons overexpressing DNMT1. Epigenomics 13:1539&#x2013;1555. https://doi.org/10.2217/epi-2021-0133</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/epi-2021-0133</ArticleId><ArticleId IdType="pubmed">34647491</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Maroju PA, Choudhury S et al (2020) Analysis of transcript levels of a few schizophrenia candidate genes in neurons from a transgenic mouse embryonic stem cell model overexpressing DNMT1. Gene 757. https://doi.org/10.1016/j.gene.2020.144934</Citation></Reference><Reference><Citation>Srancikova A, Reichova A, Bacova Z, Bakos J (2021) Gene expression levels of DNA methyltransferase enzymes in Shank3-deficient mouse model of autism during early development. Endocr Regul 55:234&#x2013;237. https://doi.org/10.2478/enr-2021-0025</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/enr-2021-0025</ArticleId><ArticleId IdType="pubmed">34879184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagarajan RP, Hogart AR, Gwye Y et al (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1:172&#x2013;182. https://doi.org/10.4161/epi.1.4.3514</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.1.4.3514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Liu Z, Mao W et al (2020) Locus-specific DNA methylation of Mecp2 promoter leads to autism-like phenotypes in mice. Cell Death Dis 11. https://doi.org/10.1038/s41419-020-2290-x</Citation></Reference><Reference><Citation>Gao Y, Duque-Wilckens N, Aljazi MB et al (2021) Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors. Commun Biol 4. https://doi.org/10.1038/s42003-021-02282-z</Citation></Reference><Reference><Citation>Pawar S, Bellver-Sanchis A, Gri&#xf1;&#xe1;n-Ferr&#xe9; C (2021) RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice. Data Br 36. https://doi.org/10.1016/j.dib.2021.107114</Citation></Reference><Reference><Citation>Gri&#xf1;&#xe1;n-Ferr&#xe9; C, Marsal-Garc&#xed;a L, Bellver-Sanchis A et al (2019) Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and &#x3b2;-amyloid plaques in an early-onset Alzheimer&#x2019;s disease mouse model. Aging (Albany NY) 11:11591&#x2013;11608. https://doi.org/10.18632/aging.102558</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102558</ArticleId><ArticleId IdType="pubmed">31804189</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang DY, Kosowan J, Samsom J et al (2018) Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice. Acta Pharmacol Sin 39:866&#x2013;874. https://doi.org/10.1038/aps.2017.190</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.190</ArticleId><ArticleId IdType="pubmed">29417943</ArticleId><ArticleId IdType="pmc">5943902</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311&#x2013;335. https://doi.org/10.1021/NP200906S</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/NP200906S</ArticleId><ArticleId IdType="pubmed">22316239</ArticleId><ArticleId IdType="pmc">3721181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok SWF, Wong VKW, Lo HH et al (2020) Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders. Pharmacol Ther 208. https://doi.org/10.1016/J.PHARMTHERA.2020.107480</Citation></Reference><Reference><Citation>Sarris J, Marx W, Ashton MM et al (2021) Plant-based medicines (phytoceuticals) in the treatment of psychiatric disorders: a meta-review of meta-analyses of randomized controlled trials: Les m&#xe9;dicaments &#xe0; base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une m&#xe9;ta-r. Can J Psychiatry 66:849&#x2013;862. https://doi.org/10.1177/0706743720979917</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0706743720979917</ArticleId><ArticleId IdType="pubmed">33596697</ArticleId><ArticleId IdType="pmc">8573706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar GP, Khanum F (2012) Neuroprotective potential of phytochemicals. Pharmacogn Rev 6:81. https://doi.org/10.4103/0973-7847.99898</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-7847.99898</ArticleId><ArticleId IdType="pubmed">23055633</ArticleId><ArticleId IdType="pmc">3459459</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryal B, Raut BK, Bhattarai S et al (2022) Potential therapeutic applications of plant-derived alkaloids against inflammatory and neurodegenerative diseases. Evidence-Based Complement Altern Med 2022:1&#x2013;18. https://doi.org/10.1155/2022/7299778</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7299778</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;peli Akkol E, Tatl&#x131; &#xc7;ankaya I, &#x15e;eker Karatoprak G et al (2021) Natural compounds as medical strategies in the prevention and treatment of psychiatric disorders seen in neurological diseases. Front Pharmacol 12. https://doi.org/10.3389/FPHAR.2021.669638/FULL</Citation></Reference><Reference><Citation>Agarwal B, Pal P, Parihar L et al (2022) Evaluation of protective effect of vinpocetine in reserpine-induced depression in Wistar rats. J Posit Sch Psychol 6:2471&#x2013;2481</Citation></Reference><Reference><Citation>Sheref AA, Naguib YM, Abou-Elnour ES et al (2022) Neuroprotective effect of piracetam and vincamine in a rat model of haloperidol-induced Parkinson&#x2019;s disease. Bull Egypt Soc Physiol Sci 42:11&#x2013;26. https://doi.org/10.21608/BESPS.2021.71203.1099</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/BESPS.2021.71203.1099</ArticleId></ArticleIdList></Reference><Reference><Citation>Leri M, Scuto M, Ontario ML et al (2020) Healthy effects of plant polyphenols: molecular mechanisms. Int J Mol Sci 21:1250. https://doi.org/10.3390/IJMS21041250</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS21041250</ArticleId><ArticleId IdType="pubmed">32070025</ArticleId><ArticleId IdType="pmc">7072974</ArticleId></ArticleIdList></Reference><Reference><Citation>Casamenti F, Stefani M (2017) Olive polyphenols: new promising agents to combat aging-associated neurodegeneration. Expert Rev Neurother 17:345&#x2013;358. https://doi.org/10.1080/14737175.2017.1245617</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2017.1245617</ArticleId><ArticleId IdType="pubmed">27762153</ArticleId></ArticleIdList></Reference><Reference><Citation>Carito V, Ceccanti M, Tarani L et al (2016) Neurotrophins&#x2019; modulation by olive polyphenols. Curr Med Chem 23:3189&#x2013;3197. https://doi.org/10.2174/0929867323666160627104022</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666160627104022</ArticleId><ArticleId IdType="pubmed">27356540</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoso F, Egerton S, Bastiaanssen TFS et al (2020) Polyphenols selectively reverse early-life stress-induced behavioural, neurochemical and microbiota changes in the rat. Psychoneuroendocrinology 116:104673. https://doi.org/10.1016/J.PSYNEUEN.2020.104673</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSYNEUEN.2020.104673</ArticleId><ArticleId IdType="pubmed">32334345</ArticleId></ArticleIdList></Reference><Reference><Citation>Caracci F, Harary J, Simkovic S, Pasinetti GM (2019) Grape-derived polyphenols ameliorate stress-induced depression by regulating synaptic plasticity. J Agric Food Chem. https://doi.org/10.1021/ACS.JAFC.9B01970/ASSET/IMAGES/MEDIUM/JF9B01970_0003.GIF</Citation></Reference><Reference><Citation>Yuan Y, Zhen L, Li Z et al (2020) trans-Resveratrol ameliorates anxiety-like behaviors and neuropathic pain in mouse model of post-traumatic stress disorder. J Psychopharmacol 34:726&#x2013;736. https://doi.org/10.1177/0269881120914221</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881120914221</ArticleId><ArticleId IdType="pubmed">32308103</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N, Zhang Y, Chen M et al (2019) Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway. Exp Gerontol 124:110653. https://doi.org/10.1016/J.EXGER.2019.110653</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EXGER.2019.110653</ArticleId><ArticleId IdType="pubmed">31295526</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa J, Rocha A, Nunes F et al (2013) Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A 2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. J Alzheimer&#x2019;s Dis 34:509&#x2013;518. https://doi.org/10.3233/JAD-111982</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-111982</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu Mallik S, Mudgal J, Hall S et al (2021) Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF. Nutr Neurosci 25:1836&#x2013;1844. https://doi.org/10.1080/1028415X.2021.1906393</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2021.1906393</ArticleId><ArticleId IdType="pubmed">33814004</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte T, Fontana BD, M&#xfc;ller TE et al (2019) Nicotine prevents anxiety-like behavioral responses in zebrafish. Prog Neuro-Psychopharmacol Biol Psychiatry 94:109655. https://doi.org/10.1016/J.PNPBP.2019.109655</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PNPBP.2019.109655</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvajal-Oliveros A, Dom&#xed;nguez-Bale&#xf3;n C, Z&#xe1;rate RV et al (2021) Nicotine suppresses Parkinson&#x2019;s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels. Sci Rep 111(11):1&#x2013;13. https://doi.org/10.1038/s41598-021-88910-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88910-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Soni R, Sharma M et al (2022) Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson&#x2019;s disease by GLP-1 secretion. Mol Neurobiol 59:6834&#x2013;6856. https://doi.org/10.1007/S12035-022-03005-Z/FIGURES/9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12035-022-03005-Z/FIGURES/9</ArticleId><ArticleId IdType="pubmed">36048341</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Li X, Meng S et al (2020) Chlorogenic acid alleviates A&#x3b2;25-35-induced autophagy and cognitive impairment via the mTOR/TFEB signaling pathway. Drug Des Devel Ther 14:1705&#x2013;1716. https://doi.org/10.2147/DDDT.S235969</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S235969</ArticleId><ArticleId IdType="pubmed">32440096</ArticleId><ArticleId IdType="pmc">7221680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X-D, Tang J-J, Feng S et al (2021) Chlorogenic acid improves PTSD-like symptoms and associated mechanisms. Curr Neuropharmacol 19:2180. https://doi.org/10.2174/1570159X19666210111155110</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X19666210111155110</ArticleId><ArticleId IdType="pubmed">33430733</ArticleId><ArticleId IdType="pmc">9185768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz M, Sadiq A, Junaid M et al (2019) Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front Aging Neurosci 11. https://doi.org/10.3389/FNAGI.2019.00155</Citation></Reference><Reference><Citation>Donato F, de Gomes MG, Goes ATR et al (2014) Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: possible role of l-arginine-NO-cGMP pathway and BDNF levels. Brain Res Bull 104:19&#x2013;26. https://doi.org/10.1016/J.BRAINRESBULL.2014.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRESBULL.2014.03.004</ArticleId><ArticleId IdType="pubmed">24709058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabogal-Gu&#xe1;queta AM, Mu&#xf1;oz-Manco JI, Ram&#xed;rez-Pineda JR et al (2015) The flavonoid quercetin ameliorates Alzheimer&#x2019;s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer&#x2019;s disease model mice. Neuropharmacology 93:134&#x2013;145. https://doi.org/10.1016/J.NEUROPHARM.2015.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROPHARM.2015.01.027</ArticleId><ArticleId IdType="pubmed">25666032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JK, Choi SJ, Cho HY et al (2014) Protective effects of kaempferol (3,4&#x2032;,5,7-tetrahydroxyflavone) against amyloid beta peptide (A&#x3b2;)-induced neurotoxicity in ICR mice. OUP 74:397&#x2013;401. https://doi.org/10.1271/BBB.90585</Citation><ArticleIdList><ArticleId IdType="doi">10.1271/BBB.90585</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzoug S, Toumi ML, Tahraoui A (2014) Quercetin mitigates Adriamycin-induced anxiety- and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol 387:921&#x2013;933. https://doi.org/10.1007/S00210-014-1008-Y/TABLES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00210-014-1008-Y/TABLES/1</ArticleId><ArticleId IdType="pubmed">24947870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Wang W, Peng Y, Deng Z (2019) Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT/&#x3b2;-catenin cascade. Metab Brain Dis 34:485&#x2013;494. https://doi.org/10.1007/S11011-019-0389-5/FIGURES/8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11011-019-0389-5/FIGURES/8</ArticleId><ArticleId IdType="pubmed">30762138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sur B, Lee B (2022) Luteolin reduces fear, anxiety, and depression in rats with post-traumatic stress disorder. Animal Cells Syst (Seoul) 26:174. https://doi.org/10.1080/19768354.2022.2104925</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19768354.2022.2104925</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Jo MH, Ikram M et al (2021) Deciphering the potential neuroprotective effects of luteolin against A&#x3b2;1&#x2013;42-induced Alzheimer&#x2019;s disease. Int J Mol Sci 9583(22):9583. https://doi.org/10.3390/IJMS22179583</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS22179583</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Wang X, Qin T et al (2016) Apigenin ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1&#x3b2; production and NLRP3 inflammasome activation in the rat brain. Behav Brain Res 296:318&#x2013;325. https://doi.org/10.1016/J.BBR.2015.09.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBR.2015.09.031</ArticleId><ArticleId IdType="pubmed">26416673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Wang JL, Liu R et al (2013) Neuroprotective, anti-amyloidogenic and neurotrophic effects of apigenin in an Alzheimer&#x2019;s disease mouse model. Mol 9949-9965(18):9949&#x2013;9965. https://doi.org/10.3390/MOLECULES18089949</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MOLECULES18089949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervin M, Unno K, Ohishi T et al (2018) Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules 23. https://doi.org/10.3390/MOLECULES23061297</Citation></Reference><Reference><Citation>Maher P (2019) The potential of flavonoids for the treatment of neurodegenerative diseases. Int J Mol Sci 20. https://doi.org/10.3390/IJMS20123056</Citation></Reference><Reference><Citation>Ahmad MH, Fatima M, Ali M et al (2021) Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson&#x2019;s disease. Neuropharmacology 201:108831. https://doi.org/10.1016/J.NEUROPHARM.2021.108831</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROPHARM.2021.108831</ArticleId><ArticleId IdType="pubmed">34655599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyab M, Farheen S, Mariyath MPM et al (2019) Antidepressant and neuroprotective effects of naringenin via Sonic Hedgehog-GLI1 cell signaling pathway in a rat model of chronic unpredictable mild stress. NeuroMolecular Med 21:250&#x2013;261. https://doi.org/10.1007/S12017-019-08538-6/FIGURES/6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12017-019-08538-6/FIGURES/6</ArticleId><ArticleId IdType="pubmed">31037465</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu A, Sharma PC, Thakur VK, Goyal RK (2021) Emerging role of flavonoids as the treatment of depression. Biomolecules 11. https://doi.org/10.3390/BIOM11121825</Citation></Reference><Reference><Citation>Manayi A, Nabavi SM, Daglia M, Jafari S (2016) Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases. Pharmacol Rep 68:671&#x2013;679. https://doi.org/10.1016/J.PHAREP.2016.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHAREP.2016.03.014</ArticleId><ArticleId IdType="pubmed">27110875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G, Gong X, Wang L et al (2017) Triptolide Promotes the clearance of &#x3b1;-synuclein by enhancing autophagy in neuronal cells. Mol Neurobiol 54:2361&#x2013;2372. https://doi.org/10.1007/S12035-016-9808-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12035-016-9808-3</ArticleId><ArticleId IdType="pubmed">26957304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazari L, Komaki S, Salehi I et al (2022) Investigation of the protective effects of lutein on memory and learning using behavioral methods in a male rat model of Alzheimer&#x2019;s disease. J Funct Foods 99:105319. https://doi.org/10.1016/J.JFF.2022.105319</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JFF.2022.105319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeni ALB, Camargo A, Dalmagro AP (2019) Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities. Pharmacol Biochem Behav 179:63&#x2013;72. https://doi.org/10.1016/J.PBB.2019.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PBB.2019.02.004</ArticleId><ArticleId IdType="pubmed">30786251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Fu Y, Zhou X et al (2016) Depression-like behaviors and heme oxygenase-1 are regulated by lycopene in lipopolysaccharide-induced neuroinflammation. J Neuroimmunol 298:1&#x2013;8. https://doi.org/10.1016/J.JNEUROIM.2016.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNEUROIM.2016.06.001</ArticleId><ArticleId IdType="pubmed">27609268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur H, Chauhan S, Sandhir R (2011) Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson&#x2019;s disease. Neurochem Res 36:1435&#x2013;1443. https://doi.org/10.1007/S11064-011-0469-3/FIGURES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11064-011-0469-3/FIGURES/2</ArticleId><ArticleId IdType="pubmed">21484267</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmin OI, Romagnolo APG, Romagnolo DF (2016) Mediterranean diet and neurodegenerative diseases. Mediterr Diet 153&#x2013;164. https://doi.org/10.1007/978-3-319-27969-5_12</Citation></Reference><Reference><Citation>Armeli F, Bonucci A, Maggi E et al (2021) Mediterranean diet and neurodegenerative diseases: the neglected role of nutrition in the modulation of the endocannabinoid system. Biomol 11:790. https://doi.org/10.3390/BIOM11060790</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOM11060790</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph J, Depp C, Shih PAB et al (2017) Modified Mediterranean diet for enrichment of short chain fatty acids: potential adjunctive therapeutic to target immune and metabolic dysfunction in schizophrenia? Front Neurosci 11:155. https://doi.org/10.3389/FNINS.2017.00155/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNINS.2017.00155/BIBTEX</ArticleId><ArticleId IdType="pubmed">28396623</ArticleId><ArticleId IdType="pmc">5366345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayes J, Schloss J, Sibbritt D (2020) Effects of polyphenols in a Mediterranean diet on symptoms of depression: a systematic literature review. Adv Nutr 11:602&#x2013;615. https://doi.org/10.1093/ADVANCES/NMZ117</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ADVANCES/NMZ117</ArticleId><ArticleId IdType="pubmed">31687743</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiei F, Salari-Moghaddam A, Larijani B et al (2019) Adherence to the Mediterranean diet and risk of depression: a systematic review and updated meta-analysis of observational studies. Nutr Rev 77:230&#x2013;239. https://doi.org/10.1093/NUTRIT/NUY070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NUTRIT/NUY070</ArticleId><ArticleId IdType="pubmed">30726966</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Rubia Ort&#xed; JE, Garc&#xed;a-Pardo MP, Drehmer E et al (2018) Improvement of main cognitive functions in patients with Alzheimer&#x2019;s disease after treatment with coconut oil enriched Mediterranean diet: a pilot study. J Alzheimer&#x2019;s Dis 65:577&#x2013;587. https://doi.org/10.3233/JAD-180184</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180184</ArticleId></ArticleIdList></Reference><Reference><Citation>Paknahad Z, Sheklabadi E, Derakhshan Y et al (2020) The effect of the Mediterranean diet on cognitive function in patients with Parkinson&#x2019;s disease: a randomized clinical controlled trial. Complement Ther Med 50:102366. https://doi.org/10.1016/J.CTIM.2020.102366</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CTIM.2020.102366</ArticleId><ArticleId IdType="pubmed">32444045</ArticleId></ArticleIdList></Reference><Reference><Citation>Visioli F, Rodr&#xed;guez-P&#xe9;rez M, G&#xf3;mez-Torres &#xd3; et al (2020) Hydroxytyrosol improves mitochondrial energetics of a cellular model of Alzheimer&#x2019;s disease. https://doi.org/10.1080/1028415X.2020.1829344</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2020.1829344</ArticleId></ArticleIdList></Reference><Reference><Citation>Solch RJ, Aigbogun JO, Voyiadjis AG et al (2022) Mediterranean diet adherence, gut microbiota, and Alzheimer&#x2019;s or Parkinson&#x2019;s disease risk: a systematic review. J Neurol Sci 434:120166. https://doi.org/10.1016/J.JNS.2022.120166</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2022.120166</ArticleId><ArticleId IdType="pubmed">35144237</ArticleId></ArticleIdList></Reference><Reference><Citation>Paknahad Z, Sheklabadi E, Moravejolahkami AR et al (2020) The effects of Mediterranean diet on severity of disease and serum total antioxidant capacity (TAC) in patients with Parkinson&#x2019;s disease: a single center, randomized controlled trial. Nutr Neurosci 25:313&#x2013;320. https://doi.org/10.1080/1028415X.2020.1751509</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2020.1751509</ArticleId><ArticleId IdType="pubmed">32319358</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik J, Kaur S, Karan M, Choudhary S (2020) Neuroprotective effect of standardized extracts of three Lactuca sativa Linn. varieties against 3-NP induced Huntington&#x2019;s disease like symptoms in rats. https://doi.org/10.1080/1028415X.2020.1841500</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2020.1841500</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight A, Bryan J, Murphy K (2016) The Mediterranean diet and age-related cognitive functioning: a systematic review of study findings and neuropsychological assessment methodology. Nutr Neurosci 20:449&#x2013;468. https://doi.org/10.1080/1028415X.2016.1183341</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2016.1183341</ArticleId><ArticleId IdType="pubmed">27192034</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolahi M, Karimi E, Sarraf P et al (2021) The omega-3 and nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial. BMC Res Notes 14:1&#x2013;7. https://doi.org/10.1186/S13104-021-05700-X/TABLES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13104-021-05700-X/TABLES/3</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade WK, de S&#xe1; Barreto da Cunha M, Miranda SS et al (2021) Non-specific effect of omega-3 fatty acid supplementation on autistic spectrum disorder: systematic review and meta-analysis. https://doi.org/10.1080/1028415X.2021.1913950</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2021.1913950</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JH, Kim G (2018) Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression. Nutr Res 50:1&#x2013;9. https://doi.org/10.1016/J.NUTRES.2017.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NUTRES.2017.10.013</ArticleId><ArticleId IdType="pubmed">29540267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu MC, Tung CY, Chen HE (2018) Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation. J Affect Disord 238:47&#x2013;61. https://doi.org/10.1016/J.JAD.2018.05.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAD.2018.05.018</ArticleId><ArticleId IdType="pubmed">29860183</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez M&#xc1;, Pe&#xf1;aloza-Sancho V, Ahumada J et al (2017) n-3 polyunsaturated fatty acid supplementation restored impaired memory and GABAergic synaptic efficacy in the hippocampus of stressed rats. Nutr Neurosci 21:556&#x2013;569. https://doi.org/10.1080/1028415X.2017.1323609</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2017.1323609</ArticleId><ArticleId IdType="pubmed">28482757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi-Rad M, Lankatillake C, Dias DA et al (2020) Impact of natural compounds on neurodegenerative disorders: from preclinical to pharmacotherapeutics. J Clin Med 9:1061. https://doi.org/10.3390/jcm9041061</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9041061</ArticleId><ArticleId IdType="pubmed">32276438</ArticleId><ArticleId IdType="pmc">7231062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J, Zhang X, Li C et al (2020) Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response. J Ethnopharmacol 254:112727. https://doi.org/10.1016/J.JEP.2020.112727</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JEP.2020.112727</ArticleId><ArticleId IdType="pubmed">32147481</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Zhang W, Ye R et al (2021) Catalpol enhanced physical exercise-mediated brain functional improvement in post-traumatic stress disorder model via promoting adult hippocampal neurogenesis. Aging (Albany NY) 13:18689. https://doi.org/10.18632/AGING.203313</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/AGING.203313</ArticleId><ArticleId IdType="pubmed">34326271</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzoubi KH, Al Hilo AS, Al-Balas QA et al (2019) Withania somnifera root powder protects againist post-traumatic stress disorder-induced memory impairment. Mol Biol Rep 46:4709&#x2013;4715. https://doi.org/10.1007/S11033-019-04915-3/FIGURES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11033-019-04915-3/FIGURES/4</ArticleId><ArticleId IdType="pubmed">31218539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Park S, Jeong KH, Kim WJ (2020) Withanolide-A treatment exerts a neuroprotective effect via inhibiting neuroinflammation in the hippocampus after pilocarpine-induced status epilepticus. Epilepsy Res 165. https://doi.org/10.1016/J.EPLEPSYRES.2020.106394</Citation></Reference><Reference><Citation>Zhu H, Wang G, Bai Y et al (2022) Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-&#x3ba;B signaling pathway. J Ethnopharmacol 289:115063. https://doi.org/10.1016/J.JEP.2022.115063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JEP.2022.115063</ArticleId><ArticleId IdType="pubmed">35149130</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares-Silva B, Beserra-Filho JIA, Morera PMA et al (2022) The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats. Neuropeptides 91:102209. https://doi.org/10.1016/J.NPEP.2021.102209</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NPEP.2021.102209</ArticleId><ArticleId IdType="pubmed">34808488</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvi AM, Al Kury LT, Alattar A et al (2021) Carveol attenuates seizure severity and neuroinflammation in pentylenetetrazole-kindled epileptic rats by regulating the Nrf2 signaling pathway. Oxid Med Cell Longev 2021. https://doi.org/10.1155/2021/9966663</Citation></Reference><Reference><Citation>Qusa MH, Abdelwahed KS, Meyer SA, El Sayed KA (2020) Olive oil lignan (+)-acetoxypinoresinol peripheral motor and neuronal protection against the tremorgenic mycotoxin penitrem A toxicity via STAT1 pathway. ACS Chem Neurosci 11:3575&#x2013;3589. https://doi.org/10.1021/ACSCHEMNEURO.0C00458</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACSCHEMNEURO.0C00458</ArticleId><ArticleId IdType="pubmed">32991800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Y, Liu M, Xu S et al (2019) Inhibition of SERPINA3N-dependent neuroinflammation is essential for melatonin to ameliorate trimethyltin chloride&#x2013;induced neurotoxicity. J Pineal Res 67:e12596. https://doi.org/10.1111/JPI.12596</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JPI.12596</ArticleId><ArticleId IdType="pubmed">31332839</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Choi BY, Kho AR et al (2018) Inhibition of NADPH oxidase activation by apocynin rescues seizure-induced reduction of adult hippocampal neurogenesis. Int J Mol Sci 19. https://doi.org/10.3390/IJMS19103087</Citation></Reference><Reference><Citation>Rodr&#xed;guez-Mu&#xf1;oz M, Onetti Y, Cort&#xe9;s-Montero E et al (2018) Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. Mol Brain 11. https://doi.org/10.1186/S13041-018-0395-2</Citation></Reference><Reference><Citation>Madadzadeh M, Abbasnejad M, Mollashahi M et al (2021) Phytohormone abscisic acid boosts pentobarbital-induced sleep through activation of GABA-A, PPAR&#x3b2; and PPAR&#x3b3; receptor signaling. Arq Neuropsiquiatr 79:216&#x2013;221. https://doi.org/10.1590/0004-282X-ANP-2019-0393</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X-ANP-2019-0393</ArticleId><ArticleId IdType="pubmed">33886795</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi K, Okauchi H, Yamamoto S, Higo-Yamamoto S (2020) Dietary natural cocoa ameliorates disrupted circadian rhythms in locomotor activity and sleep-wake cycles in mice with chronic sleep disorders caused by psychophysiological stress. Nutrition 75&#x2013;76:110751. https://doi.org/10.1016/J.NUT.2020.110751</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NUT.2020.110751</ArticleId><ArticleId IdType="pubmed">32247223</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrella C, Carito V, Carere C et al (2020) Oxidative stress inhibition by resveratrol in alcohol-dependent mice. Nutrition 79&#x2013;80. https://doi.org/10.1016/J.NUT.2020.110783</Citation></Reference><Reference><Citation>Ben-Azu B, Nwoke EE, Aderibigbe AO et al (2019) Possible neuroprotective mechanisms of action involved in the neurobehavioral property of naringin in mice. Biomed Pharmacother 109:536&#x2013;546. https://doi.org/10.1016/J.BIOPHA.2018.10.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BIOPHA.2018.10.055</ArticleId><ArticleId IdType="pubmed">30399589</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph A, Thuy TTT, Thanh LT, Okada M (2018) Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator. PLoS One 13. https://doi.org/10.1371/JOURNAL.PONE.0201092</Citation></Reference><Reference><Citation>Zhang L, Liu C, Yuan M (2020) Eriodictyol produces antidepressant-like effects and ameliorates cognitive impairments induced by chronic stress. Neuroreport 1111&#x2013;1120. https://doi.org/10.1097/WNR.0000000000001525</Citation></Reference><Reference><Citation>Zhang B, Li Y, Liu M et al (2020) Antidepressant-like mechanism of honokiol in a rodent model of corticosterone-induced depression. J Integr Neurosci 19:459&#x2013;467. https://doi.org/10.31083/J.JIN.2020.03.172/1757-448X-19-3-459/FIG8.JPG</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/J.JIN.2020.03.172/1757-448X-19-3-459/FIG8.JPG</ArticleId><ArticleId IdType="pubmed">33070525</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan HL, Zhao YL, Ding CF et al (2020) Anti-inflammatory and antinociceptive effects of Curcuma kwangsiensis and its bioactive terpenoids in vivo and in vitro. J Ethnopharmacol 259:112935. https://doi.org/10.1016/J.JEP.2020.112935</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JEP.2020.112935</ArticleId><ArticleId IdType="pubmed">32387235</ArticleId></ArticleIdList></Reference><Reference><Citation>Luduvico KP, Spohr L, Soares MSP et al (2020) Antidepressant effect and modulation of the redox system mediated by tannic acid on lipopolysaccharide-induced depressive and inflammatory changes in mice. Neurochem Res 45:2032&#x2013;2043. https://doi.org/10.1007/S11064-020-03064-5/FIGURES/7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11064-020-03064-5/FIGURES/7</ArticleId><ArticleId IdType="pubmed">32500408</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang A, Li Y, Wu X et al (2020) Baicalin attenuates inflammatory pain associated depressive symptoms via Akt-mediated adult hippocampal neurogenesis. Metab Brain Dis 35:1085&#x2013;1093. https://doi.org/10.1007/S11011-020-00599-Y/FIGURES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11011-020-00599-Y/FIGURES/4</ArticleId><ArticleId IdType="pubmed">32643091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Hu P, Zhang J et al Purpurin exerted antidepressant-like effects on behavior and stress axis reactivity: evidence of serotonergic engagement. https://doi.org/10.1007/s00213-019-05422-w</Citation></Reference><Reference><Citation>J&#xfa;nior ALG, Tchekalarova JD, da Concei&#xe7;&#xe3;o MK et al (2019) Antidepressant-like effect of anacardic acid in mice via the L-arginine&#x2013;nitric oxide&#x2013;serotonergic system. Phyther Res 33:2126&#x2013;2138. https://doi.org/10.1002/PTR.6407</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PTR.6407</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Wang J, Hao C et al Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice. https://doi.org/10.1007/s00213-019-05210-6</Citation></Reference><Reference><Citation>Khan K, Najmi AK, Akhtar M (2019) A natural phenolic compound quercetin showed the usefulness by targeting inflammatory, oxidative stress markers and augment 5-HT levels in one of the animal models of depression in mice. Drug Res (Stuttg) 69:392&#x2013;400. https://doi.org/10.1055/A-0748-5518</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/A-0748-5518</ArticleId><ArticleId IdType="pubmed">30296804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazir S, Farooq RK et al Therapeutic effect of thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model. Psychopharmacology (Berl) 1:3. https://doi.org/10.1007/s00213-021-06038-9</Citation></Reference><Reference><Citation>Vega Cust&#xf3;dio S, Spohr L, Pontes Bona N et al (2021) Effect of blueberry (Vaccinium virgatum) extract on depressive-like behavior and metabolic serum alterations in lipopolysaccharide-challenged mice. J Food Biochem 45. https://doi.org/10.1111/JFBC.13920</Citation></Reference><Reference><Citation>Wei X, Ma Y, Li F et al (2021) Acute diallyl disulfide administration prevents and reveres lipopolysaccharide-induced depression-like behaviors in mice via regulating neuroinflammation and oxido-nitrosative stress. Inflammation 44:1381&#x2013;1395. https://doi.org/10.1007/S10753-021-01423-0/FIGURES/7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10753-021-01423-0/FIGURES/7</ArticleId><ArticleId IdType="pubmed">33511484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Yang C, Chu J et al (2021) Emodin prevented depression in chronic unpredicted mild stress-exposed rats by targeting miR-139-5p/5-lipoxygenase. Front cell Dev Biol 9. https://doi.org/10.3389/FCELL.2021.696619</Citation></Reference><Reference><Citation>Tian DD, Wang M, Liu A et al (2021) Antidepressant Effect of paeoniflorin is through inhibiting pyroptosis CASP-11/GSDMD pathway. Mol Neurobiol 58:761&#x2013;776. https://doi.org/10.1007/S12035-020-02144-5/FIGURES/11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12035-020-02144-5/FIGURES/11</ArticleId><ArticleId IdType="pubmed">33025508</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Song W, Tong Y et al (2021) Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-&#x3ba;B axis. J Neuroinflammation 18. https://doi.org/10.1186/S12974-020-02040-8</Citation></Reference><Reference><Citation>Norins LC (2021) Repurposing licensed drugs for use against Alzheimer&#x2019;s disease. J Alzheimer&#x2019;s Dis 81:921. https://doi.org/10.3233/JAD-210080</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210080</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher EJR, Kaminski T, Williams G, Duty S (2021) Drug repurposing strategies of relevance for Parkinson&#x2019;s disease. Pharmacol Res Perspect 9:e00841. https://doi.org/10.1002/PRP2.841</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PRP2.841</ArticleId><ArticleId IdType="pubmed">34309236</ArticleId><ArticleId IdType="pmc">8311732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebada ME (2017) Drug repurposing may generate novel approaches to treating depression. J Pharm Pharmacol 69:1428&#x2013;1436. https://doi.org/10.1111/JPHP.12815</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JPHP.12815</ArticleId><ArticleId IdType="pubmed">28925030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YS, Marder SR, Green MF (2017) Repurposing drugs for cognition in schizophrenia. Clin Pharmacol Ther 101:191&#x2013;193. https://doi.org/10.1002/CPT.529</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/CPT.529</ArticleId><ArticleId IdType="pubmed">27706797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay RR, Majekova M, Medina M, Valoti M (2016) Key targets for multi-target ligands designed to combat neurodegeneration. Front Neurosci 10:375. https://doi.org/10.3389/FNINS.2016.00375/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNINS.2016.00375/BIBTEX</ArticleId><ArticleId IdType="pubmed">27597816</ArticleId><ArticleId IdType="pmc">4992697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay RR, Popovic-Nikolic MR, Nikolic K et al (2018) A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med 7:1&#x2013;14. https://doi.org/10.1186/S40169-017-0181-2/FIGURES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40169-017-0181-2/FIGURES/4</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzo A, Dal Bo L, Monti NC et al (2004) Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Pharmacol Res 50:77&#x2013;85. https://doi.org/10.1016/J.PHRS.2003.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHRS.2003.12.004</ArticleId><ArticleId IdType="pubmed">15082032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiteh M, Zeifman A, Saarinen M et al (2018) Docking screens for dual inhibitors of disparate drug targets for Parkinson&#x2019;s disease. J Med Chem 61:5269&#x2013;5278. https://doi.org/10.1021/ACS.JMEDCHEM.8B00204</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACS.JMEDCHEM.8B00204</ArticleId><ArticleId IdType="pubmed">29792714</ArticleId><ArticleId IdType="pmc">6716773</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesiti F, Chavarria D, Gaspar A et al (2019) The chemistry toolbox of multitarget-directed ligands for Alzheimer&#x2019;s disease. Eur J Med Chem 181:111572. https://doi.org/10.1016/J.EJMECH.2019.111572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EJMECH.2019.111572</ArticleId><ArticleId IdType="pubmed">31404859</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowska A, Wesolowska A, Pawlowski M, Chlon-Rzepa G (2018) Multi-target-directed ligands affecting serotonergic neurotransmission for Alzheimer&#x2019;s disease therapy: advances in chemical and biological research. Curr Med Chem 25:2045&#x2013;2067. https://doi.org/10.2174/0929867324666170529122802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666170529122802</ArticleId><ArticleId IdType="pubmed">28554324</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubsher G, Haider M, Okun MS (2012) Amantadine: the journey from fighting flu to treating Parkinson disease. Neurology 78:1096&#x2013;1099. https://doi.org/10.1212/WNL.0B013E31824E8F0D</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0B013E31824E8F0D</ArticleId><ArticleId IdType="pubmed">22474298</ArticleId></ArticleIdList></Reference><Reference><Citation>Meythaler JM, Brunner RC, Johnson A, Novack TA (2002) Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 17:300&#x2013;313. https://doi.org/10.1097/00001199-200208000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001199-200208000-00004</ArticleId><ArticleId IdType="pubmed">12105999</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren KD, Marangell LB (2004) Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities. Ann Gen Hosp Psychiatry 3. https://doi.org/10.1186/1475-2832-3-7</Citation></Reference><Reference><Citation>Tousi B (2015) The emerging role of bexarotene in the treatment of Alzheimer&#x2019;s disease: current evidence. Neuropsychiatr Dis Treat 11:311. https://doi.org/10.2147/NDT.S61309</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S61309</ArticleId><ArticleId IdType="pubmed">25709453</ArticleId><ArticleId IdType="pmc">4327563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner V, Miodownik C, Gibel A et al (2013) The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial. J Clin Psychiatry 74:1224&#x2013;1232. https://doi.org/10.4088/JCP.12M08160</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.12M08160</ArticleId><ArticleId IdType="pubmed">24434091</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Garza R, Asnis GM (2003) The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Res 977:70&#x2013;79. https://doi.org/10.1016/S0006-8993(03)02757-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(03)02757-4</ArticleId><ArticleId IdType="pubmed">12788515</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuve O, Weideman RA, McMahan DM et al (2020) Diclofenac reduces the risk of Alzheimer&#x2019;s disease: a pilot analysis of NSAIDs in two US veteran populations. Ther Adv Neurol Disord 13:1756286420935676. https://doi.org/10.1177/1756286420935676</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286420935676</ArticleId><ArticleId IdType="pubmed">32647537</ArticleId><ArticleId IdType="pmc">7325551</ArticleId></ArticleIdList></Reference><Reference><Citation>Carboni E, Carta AR, Carboni E, Novelli A (2021) Repurposing ketamine in depression and related disorders: can this enigmatic drug achieve success? Front Neurosci 15:469. https://doi.org/10.3389/FNINS.2021.657714/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNINS.2021.657714/BIBTEX</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Zhang Z, Kumar M et al (2019) Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3&#x3b2; pathway. Drug Des Devel Ther 13:501. https://doi.org/10.2147/DDDT.S188636</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S188636</ArticleId><ArticleId IdType="pubmed">30787593</ArticleId><ArticleId IdType="pmc">6366353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W, Xu J, Li B et al (2022) Deciphering the roles of metformin in Alzheimer&#x2019;s disease: a snapshot. Front Pharmacol 12:4123. https://doi.org/10.3389/FPHAR.2021.728315/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHAR.2021.728315/BIBTEX</ArticleId></ArticleIdList></Reference><Reference><Citation>Herv&#xe1;s D, Forn&#xe9;s-Ferrer V, G&#xf3;mez-Escribano AP et al (2017) Metformin intake associates with better cognitive function in patients with Huntington&#x2019;s disease. PLoS One 12:e0179283. https://doi.org/10.1371/JOURNAL.PONE.0179283</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0179283</ArticleId><ArticleId IdType="pubmed">28632780</ArticleId><ArticleId IdType="pmc">5478119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Luo C, Mao XY et al (2019) Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats. Brain Res 1719:30&#x2013;39. https://doi.org/10.1016/J.BRAINRES.2019.05.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRES.2019.05.023</ArticleId><ArticleId IdType="pubmed">31121159</ArticleId></ArticleIdList></Reference><Reference><Citation>Belanoff JK, Jurik J, Schatzberg LD et al (2002) Slowing the progression of cognitive decline in Alzheimer&#x2019;s disease using mifepristone. J Mol Neurosci 19:201&#x2013;206. https://doi.org/10.1007/S12031-002-0033-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12031-002-0033-3</ArticleId><ArticleId IdType="pubmed">12212781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher P, Watson S, Elizabeth Dye C et al (2008) Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia. J Psychiatr Res 42:1037&#x2013;1041. https://doi.org/10.1016/J.JPSYCHIRES.2007.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JPSYCHIRES.2007.12.005</ArticleId><ArticleId IdType="pubmed">18255098</ArticleId></ArticleIdList></Reference><Reference><Citation>Cankaya S, Cankaya B, Kilic U et al (2019) The therapeutic role of minocycline in Parkinson&#x2019;s disease. Drugs Context 8. https://doi.org/10.7573/DIC.212553</Citation></Reference><Reference><Citation>Joel Yager M (2020) Minocycline as an adjunctive treatment for depression. NEJM J Watch 2020. https://doi.org/10.1056/NEJM-JW.NA52744</Citation></Reference><Reference><Citation>La Barbera L, Vedele F, Nobili A et al (2021) Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer&#x2019;s Disease. Prog Neurobiol 202. https://doi.org/10.1016/J.PNEUROBIO.2021.102031</Citation></Reference><Reference><Citation>Krzystyniak A, Wesierska M, Petrazzo G et al (2022) Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile. Aging (Albany NY) 14:572&#x2013;595. https://doi.org/10.18632/AGING.203835</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/AGING.203835</ArticleId><ArticleId IdType="pubmed">35042834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales MM, Garbarino VR, Marques Zilli E et al (2022) Senolytic therapy to modulate the progression of Alzheimer&#x2019;s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimer&#x2019;s Dis 9:22&#x2013;29. https://doi.org/10.14283/JPAD.2021.62</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/JPAD.2021.62</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti D, Scarpini E (2016) Pioglitazone for the treatment of Alzheimer&#x2019;s disease. Expert Opin Investig Drugs 26:97&#x2013;101. https://doi.org/10.1080/13543784.2017.1265504</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2017.1265504</ArticleId><ArticleId IdType="pubmed">27885860</ArticleId></ArticleIdList></Reference><Reference><Citation>Iranpour N, Zandifar A, Farokhnia M et al (2016) The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial. Hum Psychopharmacol Clin Exp 31:103&#x2013;112. https://doi.org/10.1002/HUP.2517</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/HUP.2517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahli ZT, Tarazi FI (2018) Pimavanserin: novel pharmacotherapy for Parkinson&#x2019;s disease psychosis. Expert Opin Drug Discov 13:103&#x2013;110. https://doi.org/10.1080/17460441.2018.1394838</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2018.1394838</ArticleId><ArticleId IdType="pubmed">29047301</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastoor D, Gobburu J (2014) Clinical pharmacology review of escitalopram for the treatment of depression. Expert Opin Drug Metab Toxicol 10:121&#x2013;128. https://doi.org/10.1517/17425255.2014.863873</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.2014.863873</ArticleId><ArticleId IdType="pubmed">24289655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YJ, Gong WG, Ren QG, Zhang ZJ (2020) Escitalopram alleviates Alzheimer&#x2019;s disease-type tau pathologies in the aged P301L tau transgenic mice. J Alzheimers Dis 77:807&#x2013;819. https://doi.org/10.3233/JAD-200401</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200401</ArticleId><ArticleId IdType="pubmed">32741828</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong X, Jiang L, Qu M et al (2020) Enhancing therapeutic efficacy of donepezil by combined therapy: a comprehensive review. Curr Pharm Des 27:332&#x2013;344. https://doi.org/10.2174/1381612826666201023144836</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612826666201023144836</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada-Takatori Y (2021) Donepezil reduces amyloid precursor protein endocytosis by resulting from increase in the expression of sorting nexin protein 33. Yakugaku Zasshi 141:851&#x2013;856. https://doi.org/10.1248/YAKUSHI.20-00251-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/YAKUSHI.20-00251-6</ArticleId><ArticleId IdType="pubmed">34078793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonstad S, Arons C, Rollema H et al (2020) Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations. Curr Med Res Opin 36:713&#x2013;730. https://doi.org/10.1080/03007995.2020.1729708</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2020.1729708</ArticleId><ArticleId IdType="pubmed">32050807</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R, B&#xf6;l&#xfc;kba&#x15f;i Hatip F, A&#xe7;ikalin &#xd6; et al (2018) Effect of varenicline on behavioral deficits in a rat model of Parkinson&#x2019;s disease induced by unilateral 6-hydroxydopamine lesion of substantia nigra. Behav Pharmacol 29:327&#x2013;335. https://doi.org/10.1097/FBP.0000000000000355</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FBP.0000000000000355</ArticleId><ArticleId IdType="pubmed">29064842</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemutlu Samur D, Ak&#xe7;ay G, Y&#x131;ld&#x131;r&#x131;m S et al (2022) Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson&#x2019;s disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology 208. https://doi.org/10.1016/J.NEUROPHARM.2022.108977</Citation></Reference><Reference><Citation>Chung ES, Bok E, Chung YC et al (2012) Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase. Brain Res 1451:110&#x2013;116. https://doi.org/10.1016/J.BRAINRES.2012.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BRAINRES.2012.02.058</ArticleId><ArticleId IdType="pubmed">22436849</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;cke M, Phillips T, Radbruch L et al (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane database Syst Rev 3. https://doi.org/10.1002/14651858.CD012182.PUB2</Citation></Reference><Reference><Citation>Ineichen BV, Moridi T, Granberg T, Piehl F (2020) Rituximab treatment for multiple sclerosis. Mult Scler 26:137&#x2013;152. https://doi.org/10.1177/1352458519858604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458519858604</ArticleId><ArticleId IdType="pubmed">31237800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves CL, Vasconcelos FFP, Wessler LB et al (2020) Exposure to a high dose of amoxicillin causes behavioral changes and oxidative stress in young zebrafish. Metab Brain Dis 35:1407&#x2013;1416. https://doi.org/10.1007/S11011-020-00610-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11011-020-00610-6</ArticleId><ArticleId IdType="pubmed">32876824</ArticleId></ArticleIdList></Reference><Reference><Citation>Llorca PM, Fernandez JL (2007) Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation. Int J Clin Pract 61:702&#x2013;710. https://doi.org/10.1111/j.1742-1241.2007.01335.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2007.01335.x</ArticleId><ArticleId IdType="pubmed">17394446</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizak A, Duda P, Pielka E et al (2020) GSK3 and miRNA in neural tissue: from brain development to neurodegenerative diseases. Biochim Biophys Acta &#x2013; Mol Cell Res 1867</Citation></Reference><Reference><Citation>Gugliandolo A, Chiricosta L, Boccardi V et al (2020) Micrornas modulate the pathogenesis of Alzheimer&#x2019;s disease: an in silico analysis in the human brain. Genes (Basel) 11:1&#x2013;13. https://doi.org/10.3390/genes11090983</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11090983</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran S, Bonchev D (2016) Network analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting Huntington&#x2019;s disease. Comput Struct Biotechnol J 14:117&#x2013;130. https://doi.org/10.1016/j.csbj.2016.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2016.02.001</ArticleId><ArticleId IdType="pubmed">27924190</ArticleId><ArticleId IdType="pmc">5128196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AWS, Kocerha J (2012) The path to microRNA therapeutics in psychiatric and neurodegenerative disorders. Front Genet 3. https://doi.org/10.3389/fgene.2012.00082</Citation></Reference><Reference><Citation>Hunsberger JG, Fessler EB, Chibane FL et al (2013) Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions. Am J Transl Res 5(4):450</Citation><ArticleIdList><ArticleId IdType="pubmed">23724168</ArticleId><ArticleId IdType="pmc">3665918</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu CH, Han XY, Tong L et al (2021) miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 414. https://doi.org/10.1016/j.bbr.2021.113485</Citation></Reference><Reference><Citation>Li J, Li D, Huatao Z et al (2020) MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP-PS1 mice 2020. Aging 12:20728&#x2013;20742. https://doi.org/10.18632/aging.104005</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.104005</ArticleId><ArticleId IdType="pubmed">33087587</ArticleId><ArticleId IdType="pmc">7655176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Zhang T, Xiu W et al (2020) MiR-107 overexpression attenuates neurotoxicity induced by 6-hydroxydopamine both in vitro and in vivo. Chem Biol Interact 315. https://doi.org/10.1016/j.cbi.2019.108908</Citation></Reference><Reference><Citation>Scarr E, Craig JM, Cairns MJ et al (2013) Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl Psychiatry 3. https://doi.org/10.1038/tp.2013.3</Citation></Reference><Reference><Citation>Tao Z, Feng C, Mao C et al (2019) MiR-4465 directly targets PTEN to inhibit AKT/mTOR pathway&#x2013;mediated autophagy. Cell Stress Chaperones 24:105&#x2013;113. https://doi.org/10.1007/s12192-018-0946-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-018-0946-6</ArticleId><ArticleId IdType="pubmed">30421325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu Y, Qian J, Wang C (2020) Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson&#x2019;s disease patients. Open Life Sci 15:647&#x2013;653. https://doi.org/10.1515/biol-2020-0060</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/biol-2020-0060</ArticleId><ArticleId IdType="pubmed">33817253</ArticleId><ArticleId IdType="pmc">7747498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C, Li Y, Lan T et al (2022) Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression - PubMed. Mol Ther 30:1300&#x2013;1314. https://doi.org/10.1016/j.ymthe.2021.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.11.006</ArticleId><ArticleId IdType="pubmed">34768001</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CP, Zhong M, Sun JX et al (2021) miR-146a reduces depressive behavior by inhibiting microglial activation. Mol Med Rep 23. https://doi.org/10.3892/MMR.2021.12102</Citation></Reference><Reference><Citation>Oliveira SR, Dion&#xed;sio PA, Gaspar MM et al (2021) miR-335 targets LRRK2 and mitigates inflammation in Parkinson&#x2019;s disease. Front Cell Dev Biol 9. https://doi.org/10.3389/FCELL.2021.661461</Citation></Reference><Reference><Citation>Li X, Si W, Li Z et al (2021) miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson&#x2019;s disease. Int J Mol Med 47. https://doi.org/10.3892/ijmm.2021.4894</Citation></Reference><Reference><Citation>De Luna N, Turon-Sans J, Cortes-Vicente E et al (2020) Downregulation of miR-335-5P in amyotrophic lateral sclerosis can contribute to neuronal mitochondrial dysfunction and apoptosis. Sci Rep 10. https://doi.org/10.1038/s41598-020-61246-1</Citation></Reference><Reference><Citation>Li J, Meng H, Cao W, Qiu T (2015) MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4. Neurosci Lett 606:167&#x2013;172. https://doi.org/10.1016/j.neulet.2015.08.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.08.038</ArticleId><ArticleId IdType="pubmed">26314506</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Xu Y, Zhao M, Gao Z (2020) Neuro-protective roles of long non-coding RNA MALAT1 in Alzheimer&#x2019;s disease with the involvement of the microRNA-30b/CNR1 network and the following PI3K/AKT activation. Exp Mol Pathol 104545:117. https://doi.org/10.1016/j.yexmp.2020.104545</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexmp.2020.104545</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai LJ, Tu L, Huang XM et al (2020) LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson&#x2019;s disease. Mol Brain 13:130. https://doi.org/10.1186/s13041-020-00656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00656-8</ArticleId><ArticleId IdType="pubmed">32972446</ArticleId><ArticleId IdType="pmc">7513532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallah H, Azari I, Neishabouri SM et al (2019) Sex-specific up-regulation of lncRNAs in peripheral blood of patients with schizophrenia. Sci Rep 9. https://doi.org/10.1038/s41598-019-49265-z</Citation></Reference><Reference><Citation>Dong L-X, Zhang Y-Y, Bao H-L et al (2021) LncRNA NEAT1 promotes Alzheimer&#x2019;s disease by down regulating micro-27a-3p. Am J Transl Res 13:8885&#x2013;8896</Citation><ArticleIdList><ArticleId IdType="pubmed">34540002</ArticleId><ArticleId IdType="pmc">8430163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke S, Yang Z, Yang F et al (2019) Long noncoding RNA NEAT1 aggravates A&#x3b2;-induced neuronal damage by targeting miR-107 in Alzheimer&#x2019;s disease. Yonsei Med J 60:640&#x2013;650. https://doi.org/10.3349/ymj.2019.60.7.640</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2019.60.7.640</ArticleId><ArticleId IdType="pubmed">31250578</ArticleId><ArticleId IdType="pmc">6597469</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, Nakagawa S, Okano H (2021) NEAT1 lncRNA and amyotrophic lateral sclerosis. Neurochem Int 105175:150. https://doi.org/10.1016/j.neuint.2021.105175</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2021.105175</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsel P, Roussos P, Fam P et al (2019) The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription. npj Schizophr 5. https://doi.org/10.1038/s41537-019-0071-2</Citation></Reference><Reference><Citation>Fan Y, Zhao X, Lu K, Cheng G (2020) LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson&#x2019;s disease via ablating microRNA-125b-5p. Brain Res Bull 157:119&#x2013;127. https://doi.org/10.1016/j.brainresbull.2020.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2020.02.003</ArticleId><ArticleId IdType="pubmed">32057951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Luan W, Shen X et al (2022) LncRNA BDNF-AS as ceRNA regulates the miR-9-5p/BACE1 pathway affecting neurotoxicity in Alzheimer&#x2019;s disease. Arch Gerontol Geriatr 99. https://doi.org/10.1016/j.archger.2021.104614</Citation></Reference><Reference><Citation>Guo CC, Hong JC, Gao ZM (2018) Silencing of LncRNA BDNF-AS attenuates A&#x3b2;25-35-induced neurotoxicity in PC12 cells by suppressing cell apoptosis and oxidative stress. Neurol Res 40:795&#x2013;804. https://doi.org/10.1080/01616412.2018.1480921</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2018.1480921</ArticleId><ArticleId IdType="pubmed">29902125</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrlou E, Ghafouri-Fard S, Omrani MD et al (2021) Expression of BDNF-associated lncRNAs in treatment-resistant schizophrenia patients. J Mol Neurosci 71:2249&#x2013;2259. https://doi.org/10.1007/s12031-020-01772-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01772-9</ArticleId><ArticleId IdType="pubmed">33403596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao X, Ju W et al (2015) Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder. Transl Psychiatry 5. https://doi.org/10.1038/tp.2015.144</Citation></Reference><Reference><Citation>Zhou WY, Cai ZR, Liu J et al (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19</Citation></Reference><Reference><Citation>Altesha MA, Ni T, Khan A et al (2019) Circular RNA in cardiovascular disease. J Cell Physiol 234:5588&#x2013;5600</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27384</ArticleId><ArticleId IdType="pubmed">30341894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xu P, Chen B et al (2018) Identifying circRNA-associated-ceRNA networks in the hippocampus of A&#xdf;1-42-induced Alzheimer&#x2019;s disease-like rats using microarray analysis. Aging (Albany NY) 10:775&#x2013;788. https://doi.org/10.18632/aging.101427</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101427</ArticleId><ArticleId IdType="pubmed">29706607</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JL, Xu ZH, Yang SM et al (2018) Identification of differentially expressed profiles of Alzheimer&#x2019;s disease associated circular RNAs in a Panax notoginseng saponins-treated Alzheimer&#x2019;s disease mouse model. Comput Struct Biotechnol J 16:523&#x2013;531. https://doi.org/10.1016/j.csbj.2018.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2018.10.010</ArticleId><ArticleId IdType="pubmed">30524667</ArticleId><ArticleId IdType="pmc">6260282</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun F, Zhang Y, Wu X et al (2022) Breviscapine combined with BMSCs reduces A&#x3b2; deposition in rat with Alzheimer&#x2019;s disease by regulating circular RNA ciRS-7. Curr Mol Med 22. https://doi.org/10.2174/1566524022666220113151044</Citation></Reference><Reference><Citation>Zhang Y, Du L, Bai Y et al (2020) CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination. Mol Psychiatry 25:1175&#x2013;1190. https://doi.org/10.1038/s41380-018-0285-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-018-0285-0</ArticleId><ArticleId IdType="pubmed">30413800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar L, Shamsuzzama JP et al (2018) Functional characterization of novel circular RNA molecule, circzip-2 and its synthesizing gene zip-2 in C. elegans model of Parkinson&#x2019;s disease. Mol Neurobiol 55:6914&#x2013;6926. https://doi.org/10.1007/s12035-018-0903-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0903-5</ArticleId><ArticleId IdType="pubmed">29363043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillardon F, Mack M, Rist W et al (2008) MicroRNA and proteome expression profiling in early-symptomatic &#x3b1;-synuclein(A30P)-transgenic mice. Proteomics - Clin Appl 2:697&#x2013;705. https://doi.org/10.1002/prca.200780025</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.200780025</ArticleId><ArticleId IdType="pubmed">21136867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Zhang F, Zheng Y et al (2021) The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder. Neurosci Lett 763. https://doi.org/10.1016/j.neulet.2021.136184</Citation></Reference><Reference><Citation>Sierksma A, Lu A, Salta E et al (2018) Deregulation of neuronal miRNAs induced by amyloid-&#x3b2; or TAU pathology 11 Medical and Health Sciences 1109 Neurosciences. Mol Neurodegener 13. https://doi.org/10.1186/s13024-018-0285-1</Citation></Reference><Reference><Citation>Han L, Tang Y, Bai X et al (2020) Association of the serum microRNA-29 family with cognitive impairment in Parkinson&#x2019;s disease. Aging (Albany NY) 12:13518&#x2013;13528. https://doi.org/10.18632/aging.103458</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103458</ArticleId><ArticleId IdType="pubmed">32649312</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chan MC, Yu Y et al (2017) MiR-29b contributes to multiple types of muscle atrophy. Nat Commun 8. https://doi.org/10.1038/ncomms15201</Citation></Reference><Reference><Citation>Pereira PA, Tom&#xe1;s JF, Queiroz JA et al (2016) Recombinant pre-miR-29b for Alzheimer&#x2019;s disease therapeutics. Sci Rep 6. https://doi.org/10.1038/srep19946</Citation></Reference><Reference><Citation>Sarachana T, Zhou R, Chen G et al (2010) Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med 2. https://doi.org/10.1186/gm144</Citation></Reference><Reference><Citation>Thomas KT, Zakharenko SS (2021) MicroRNAs in the onset of schizophrenia. Cells 10</Citation></Reference><Reference><Citation>Wan YQ, Feng JG, Li M et al (2018) Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats. Exp Mol Med 50. https://doi.org/10.1038/s12276-018-0164-4</Citation></Reference><Reference><Citation>Lo Iacono L, Ielpo D, Parisi C et al (2021) MicroRNA-34a regulates 5-HT2C expression in dorsal raphe and contributes to the anti-depressant-like effect of fluoxetine. Neuropharmacology 190. https://doi.org/10.1016/j.neuropharm.2021.108559</Citation></Reference><Reference><Citation>Ma Q, Dasgupta C, Li Y et al (2016) Inhibition of microRNA-210 provides neuroprotection in hypoxic-ischemic brain injury in neonatal rats. Neurobiol Dis 89:202&#x2013;212. https://doi.org/10.1016/j.nbd.2016.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.02.011</ArticleId><ArticleId IdType="pubmed">26875527</ArticleId><ArticleId IdType="pmc">4785034</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau MP, Bruse SE, David-Rus R et al (2011) Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry 69:188&#x2013;193. https://doi.org/10.1016/j.biopsych.2010.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.09.039</ArticleId><ArticleId IdType="pubmed">21183010</ArticleId><ArticleId IdType="pmc">3038345</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunomura A, Perry G (2020) RNA and oxidative stress in Alzheimer&#x2019;s disease: focus on microRNAs. Oxid Med Cell Longev 2020</Citation></Reference><Reference><Citation>Watts ME, Williams SM, Nithianantharajah J, Claudianos C (2018) Hypoxia-induced microRNA-210 targets neurodegenerative pathways. Non-coding RNA 4. https://doi.org/10.3390/ncrna4020010</Citation></Reference><Reference><Citation>Piscopo P, Grasso M, Puopolo M et al (2018) Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia. J Alzheimer&#x2019;s Dis 65:455&#x2013;464. https://doi.org/10.3233/JAD-180364</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180364</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo JA, Carter BS, Meng F et al (2016) The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression. J Psychiatr Res 82:58&#x2013;67. https://doi.org/10.1016/j.jpsychires.2016.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2016.07.012</ArticleId><ArticleId IdType="pubmed">27468165</ArticleId><ArticleId IdType="pmc">5026930</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuoka M, Takahashi M, Fujita H et al (2018) Supplemental treatment for Huntington&#x2019;s disease with miR-132 that is deficient in Huntington&#x2019;s disease brain. Mol Ther - Nucleic Acids 11:79&#x2013;90. https://doi.org/10.1016/j.omtn.2018.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2018.01.007</ArticleId><ArticleId IdType="pubmed">29858092</ArticleId><ArticleId IdType="pmc">5852323</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wang H, Bei J et al (2021) The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer&#x2019;s disease. Am J Transl Res 13:4632&#x2013;4643</Citation><ArticleIdList><ArticleId IdType="pubmed">34150043</ArticleId><ArticleId IdType="pmc">8205745</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BH, Zeier Z, Xi L et al (2012) MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A 109:3125&#x2013;3130. https://doi.org/10.1073/pnas.1113793109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1113793109</ArticleId><ArticleId IdType="pubmed">22315408</ArticleId><ArticleId IdType="pmc">3286960</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscher E, Goupil C, Petry S et al (2021) MicroRNA-138 overexpression alters A&#x3b2;42 levels and behavior in wildtype mice. Front Neurosci 14. https://doi.org/10.3389/fnins.2020.591138</Citation></Reference><Reference><Citation>Bridget M, Peplow P (2021) Altered microRNA expression in animal models of Huntington&#x2019;s disease and potential therapeutic strategies. Neural Regen Res 16:2159&#x2013;2169</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.310673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mui&#xf1;os-Gimeno M, Espinosa-Parrilla Y, Guidi M et al (2011) Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 69:526&#x2013;533. https://doi.org/10.1016/j.biopsych.2010.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.10.010</ArticleId><ArticleId IdType="pubmed">21168126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadehbagheri F, Hosseini E, Bagheri-Hosseinabadi Z et al (2019) Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations. J Psychiatr Res 109:185&#x2013;192. https://doi.org/10.1016/j.jpsychires.2018.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2018.12.013</ArticleId><ArticleId IdType="pubmed">30557705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghose J, Sinha M, Das E et al (2011) Regulation of miR-146a by RelA/NFkB and p53 in STHdh q111/Hdh q111 cells, a cell model of Huntington&#x2019;s disease. PLoS One 6. https://doi.org/10.1371/journal.pone.0023837</Citation></Reference><Reference><Citation>Dinan TG (2010) MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. Int J Neuropsychopharmacol 13:395&#x2013;404</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1461145709990800</ArticleId><ArticleId IdType="pubmed">19849891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Ortiz CJ, Prieto GA, Martini AC et al (2020) miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer&#x2019;s disease. Aging Cell 19. https://doi.org/10.1111/acel.13118</Citation></Reference><Reference><Citation>Soliman R, Mousa NO, Rashed HR et al (2021) Assessment of diagnostic potential of some circulating microRNAs in amyotrophic lateral sclerosis patients, an Egyptian study. Clin Neurol Neurosurg 208. https://doi.org/10.1016/j.clineuro.2021.106883</Citation></Reference><Reference><Citation>Gou M, Pan S, Tong J et al (2021) Effects of microRNA-181b-5p on cognitive deficits in first-episode patients with schizophrenia: mediated by BCL-2. J Psychiatr Res 136:358&#x2013;365. https://doi.org/10.1016/j.jpsychires.2021.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.02.003</ArticleId><ArticleId IdType="pubmed">33636692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Xu X, Dong R et al (2019) MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice. Cytokine 120:41&#x2013;53. https://doi.org/10.1016/j.cyto.2019.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.04.005</ArticleId><ArticleId IdType="pubmed">31003188</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q, Wang S, Chen J et al (2019) MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson&#x2019;s disease mouse model. J Cell Physiol 234:23379&#x2013;23387. https://doi.org/10.1002/jcp.28907</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28907</ArticleId><ArticleId IdType="pubmed">31232472</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Cao XC (2019) MiR-190-5p in human diseases. Cancer Cell Int 19</Citation></Reference><Reference><Citation>Wang M, Li Z, Zuo Q (2020) miR-194-5p inhibits LPS-induced astrocytes activation by directly targeting neurexophilin 1. Mol Cell Biochem 471:203&#x2013;213. https://doi.org/10.1007/s11010-020-03780-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-03780-0</ArticleId><ArticleId IdType="pubmed">32533463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Cheng Y, Han H et al (2019) MiR-194 accelerates apoptosis of A&#x3b2;1-42-transduced hippocampal neurons by inhibiting nrn1 and decreasing PI3K/Akt signaling pathway activity. Genes (Basel) 10. https://doi.org/10.3390/genes10040313</Citation></Reference><Reference><Citation>Li Y, Fan C, Gao R et al (2021) Hippocampal miR-211-5p regulates neurogenesis and depression-like behaviors in the rat. Neuropharmacology 194. https://doi.org/10.1016/j.neuropharm.2021.108618</Citation></Reference><Reference><Citation>Liu XH, Ning FB, Zhao DP et al (2021) Role of miR-211 in a PC12 cell model of Alzheimer&#x2019;s disease via regulation of neurogenin 2. Exp Physiol 106:1061&#x2013;1071. https://doi.org/10.1113/EP088953</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP088953</ArticleId><ArticleId IdType="pubmed">33527539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim AH, Reimers M, Maher B et al (2010) MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res 124:183&#x2013;191. https://doi.org/10.1016/j.schres.2010.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2010.07.002</ArticleId><ArticleId IdType="pubmed">20675101</ArticleId><ArticleId IdType="pmc">4373420</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Chang X, Hahn CG et al (2018) Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease. Transl Psychiatry 8. https://doi.org/10.1038/s41398-017-0030-5</Citation></Reference><Reference><Citation>Stojanovic T, Benes H, Awad A et al (2021) Nicotine abolishes memory-related synaptic strengthening and promotes synaptic depression in the neurogenic dentate gyrus of miR-132/212 knockout mice. Addict Biol 26. https://doi.org/10.1111/adb.12905</Citation></Reference><Reference><Citation>Sun S, Han X, Li X et al (2018) MicroRNA-212-5p Prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson&#x2019;s disease. Front Mol Neurosci. https://doi.org/10.3389/fnmol.2018.00381</Citation></Reference><Reference><Citation>Wang Y, Chang Q (2020) MicroRNA miR-212 regulates PDCD4 to attenuate A&#x3b2;25&#x2013;35-induced neurotoxicity via PI3K/AKT signaling pathway in Alzheimer&#x2019;s disease. Biotechnol Lett 42:1789&#x2013;1797. https://doi.org/10.1007/s10529-020-02915-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-020-02915-z</ArticleId><ArticleId IdType="pubmed">32474742</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai X, Liu J, Ni A, Ye J (2020) MiR-497 promotes microglia activation and proinflammatory cytokines production in chronic unpredictable stress-induced depression via targeting FGF2. J Chem Neuroanat 110. https://doi.org/10.1016/j.jchemneu.2020.101872</Citation></Reference><Reference><Citation>Zhu L, Lin M, Ma J et al (2019) The role of LINC00094/miR-224-5p (miR-497-5p)/endophilin-1 axis in memantine mediated protective effects on blood-brain barrier in AD microenvironment. J Cell Mol Med 23:3280&#x2013;3292. https://doi.org/10.1111/jcmm.14214</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14214</ArticleId><ArticleId IdType="pubmed">30801976</ArticleId><ArticleId IdType="pmc">6484416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Zhang H, Gao J, Xu Y (2021) Silencing of miR-497-5p inhibits cell apoptosis and promotes autophagy in Parkinson&#x2019;s disease by upregulation of FGF2. Environ Toxicol 36:2302&#x2013;2312. https://doi.org/10.1002/tox.23344</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.23344</ArticleId><ArticleId IdType="pubmed">34459097</ArticleId></ArticleIdList></Reference><Reference><Citation>Devon RS, Anderson S, Teague PW et al (2001) Identification of polymorphisms within disrupted in Schizophrenia 1 and disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet 11:71&#x2013;78. https://doi.org/10.1097/00041444-200106000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041444-200106000-00003</ArticleId><ArticleId IdType="pubmed">11525420</ArticleId></ArticleIdList></Reference><Reference><Citation>King CA, Katz SH, Ghaziuddin N et al (1997) Diagnosis and assessment of depression and suicidality using the NIMH diagnostic interview schedule for children (DISC-2.3). J Abnorm Child Psychol 25:173&#x2013;181. https://doi.org/10.1023/A:1025739730823</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025739730823</ArticleId><ArticleId IdType="pubmed">9212370</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamizkar KH, Ghafouri-Fard S, Omrani MD et al (2021) Altered expression of lncRNAs in autism spectrum disorder. Metab Brain Dis 36:983&#x2013;990. https://doi.org/10.1007/s11011-021-00681-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-021-00681-z</ArticleId><ArticleId IdType="pubmed">33587235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunwoo JS, Lee ST, Im W et al (2017) Altered expression of the long noncoding RNA NEAT1 in Huntington&#x2019;s disease. Mol Neurobiol 54:1577&#x2013;1586. https://doi.org/10.1007/s12035-016-9928-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9928-9</ArticleId><ArticleId IdType="pubmed">27221610</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari M, Noroozi R, Taheri M, Ghafouri-Fard S (2020) The rs12826786 in HOTAIR lncRNA is associated with risk of autism spectrum disorder. J Mol Neurosci 70:175&#x2013;179. https://doi.org/10.1007/s12031-019-01421-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-019-01421-w</ArticleId><ArticleId IdType="pubmed">31654274</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri M, Noroozi R, Sadeghpour S et al (2020) The rs4759314 SNP within Hotair lncRNA is associated with risk of multiple sclerosis. Mult Scler Relat Disord 101986:40. https://doi.org/10.1016/j.msard.2020.101986</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.101986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Huang XM, Liao JX et al (2021) LncRNA HOTAIR promotes neuronal damage through facilitating NLRP3 mediated-pyroptosis activation in Parkinson&#x2019;s disease via regulation of miR-326/ELAVL1 axis. Cell Mol Neurobiol 41:1773&#x2013;1786. https://doi.org/10.1007/s10571-020-00946-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00946-8</ArticleId><ArticleId IdType="pubmed">32968928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Li H, Chang N (2020) LncRNA hotair promotes MPP+-induced neuronal injury in Parkinson&#x2019;s disease by regulating the miR-874-5p/ATG10 axis. EXCLI J 19:1141&#x2013;1153. https://doi.org/10.17179/excli2020-2286</Citation><ArticleIdList><ArticleId IdType="doi">10.17179/excli2020-2286</ArticleId><ArticleId IdType="pubmed">33013268</ArticleId><ArticleId IdType="pmc">7527508</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley EMM (2017) Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep 17:1&#x2013;9. https://doi.org/10.1007/S11910-017-0802-6/FIGURES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11910-017-0802-6/FIGURES/2</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>